2017

1) Armbrecht, G., Felsenberg, D., Ganswindt, M., Lunt, M., Kaptoge, S. K., Abendroth, K., et al. (2017). “Degenerative inter-vertebral disc disease osteochondrosis intervertebralis in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.” Rheumatology 07: 07.

2) Barker, M., D’Angelo, S., Ntani, G., Lawrence, W., Baird, J., Jarman, M., et al. (2017). “The relationship between maternal self-efficacy, compliance and outcome in a trial of vitamin D supplementation in pregnancy.” Osteoporosis International 28(1): 77-84.

3) Bayliss, L. E., Culliford, D., Monk, A. P., Glyn-Jones, S., Prieto-Alhambra, D., Judge, A., et al. (2017). “The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study.” The Lancet 389(10077): 1424-1430.

4) Beaudart, C., Dawson, A., Shaw, S. C., Harvey, N. C., Kanis, J. A., Binkley, N., et al. (2017). “Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review.” Osteoporosis International 28(6): 1817-1833.

5) Bishop, F. L., Yardley, L., Cooper, C., Little, P. and Lewith, G. (2017). “Predicting adherence to acupuncture appointments for low back pain: A prospective observational study.” BMC Complementary and Alternative Medicine 17(1).

6) Christoffersen, T., Ahmed, L. A., Daltveit, A. K., Dennison, E. M., Evensen, E. K., Furberg, A. S., et al. (2017). “The influence of birth weight and length on bone mineral density and content in adolescence: The Tromso Study, Fit Futures.” Archives of Osteoporosis 12(1): 54.

7) Coutts, L. V., Jenkins, T., Oreffo, R. O. C., Dunlop, D. G., Cooper, C., Harvey, N. C., et al. (2017). “Local Variation in Femoral Neck Cortical Bone: In Vitro Measured Bone Mineral Density, Geometry and Mechanical Properties.” Journal of Clinical Densitometry 20(2): 205-215.

8) Crabtree, N. J., Shaw, N. J., Bishop, N. J., Adams, J. E., Mughal, M. Z., Arundel, P., et al. (2017). “Amalgamated Reference Data for Size-Adjusted Bone Densitometry Measurements in 3598 Children and Young Adults-the ALPHABET Study.” Journal of Bone & Mineral Research 32(1): 172-180.

9) Curtis, E. M., Murray, R., Titcombe, P., Cook, E., Clarke-Harris, R., Costello, P., et al. (2017). “Perinatal DNA Methylation at CDKN2A Is Associated With Offspring Bone Mass: Findings From the Southampton Women’s Survey.” Journal of Bone and Mineral Research.

10) Driessen, J. H. M., de Vries, F., van Onzenoort, H., Harvey, N. C., Neef, C., van den Bergh, J. P. W., et al. (2017). “The use of incretins and fractures – a meta-analysis on population-based real life data.” British Journal of Clinical Pharmacology 83(4): 923-926.

11) Edwards, M. H., Paccou, J., Ward, K. A., Jameson, K. A., Moss, C., Woolston, J., et al. (2017). “The relationship of bone properties using high resolution peripheral quantitative computed tomography to radiographic components of hip osteoarthritis.” Osteoarthritis and Cartilage Date of Publication.

12) Hadji, P., Aapro, M. S., Body, J. J., Gnant, M., Brandi, M. L., Reginster, J. Y., et al. (2017). “Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG.” Journal of Bone Oncology 7(pp 1-12).

13) Hamill, M. M., Pettifor, J. M., Ward, K. A., Norris, S. A. and Prentice, A. (2017). “Changes in Bone Mineral Density, Body Composition, Vitamin D Status, and Mineral Metabolism in Urban HIV-Positive South African Women Over 12 Months.” Journal of Bone and Mineral Research.

14) Handel, M. N., Frederiksen, P., Cohen, A., Cooper, C., Heitmann, B. L. and Abrahamsen, B. (2017). “Neonatal vitamin D status from archived dried blood spots and future risk of fractures in childhood: results from the D-tect study, a population-based case-cohort study.” American Journal of Clinical Nutrition 17: 17.

15) Handel, M. N., Frederiksen, P., Osmond, C., Cooper, C., Abrahamsen, B. and Heitmann, B. L. (2017). “Prenatal exposure to Vitamin D from fortified margarine and risk of fractures in late childhood: Period and cohort results from 222 000 subjects in the D-tect observational study.” British Journal of Nutrition 117(6): 872-881.

16) Hannam, K., Deere, K. C., Hartley, A., Clark, E. M., Coulson, J., Ireland, A., et al. (2017). “A novel accelerometer-based method to describe day-to-day exposure to potentially osteogenic vertical impacts in older adults: findings from a multi-cohort study.” Osteoporosis International 28(3): 1001-1011.

17) Hiligsmann, M., Dellaert, B. G., Dirksen, C. D., Watson, V., Bours, S., Goemaere, S., et al. (2017). “Patients’ preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment.” Rheumatology 06: 06.

18) Ireland, A., Muthuri, S., Rittweger, J., Adams, J. E., Ward, K. A., Kuh, D., et al. (2017). “Later Age at Onset of Independent Walking Is Associated With Lower Bone Strength at Fracture-Prone Sites in Older Men.” Journal of Bone and Mineral Research 32(6): 1209-1217.

19) Jackson, K. A., Sanchez-Santos, M. T., MacKinnon, A. L., Turner, A., Kuznik, K., Ellis, S., et al. (2017). “Bone density and body composition in newly licenced professional jockeys.” Osteoporosis International.

20) Johansson, H., Siggeirsdottir, K., Harvey, N. C., Oden, A., Gudnason, V., McCloskey, E., et al. (2017). “Imminent risk of fracture after fracture.” Osteoporosis International 28(3): 775-780.

21) Klop, C., van Staa, T. P., Cooper, C., Harvey, N. C. and de Vries, F. (2017). “The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity.” Osteoporosis International 28(1): 161-168.

22) Leal, J., Gray, A. M., Hawley, S., Prieto-Alhambra, D., Delmestri, A., Arden, N. K., et al. (2017). “Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study.” Journal of Bone and Mineral Research 32(2): 203-211.

23) Ledingham, J. M., Snowden, N., Rivett, A., Galloway, J., Ide, Z., Firth, J., et al. (2017). “Patient- and clinician-reported outcomes for patients with new presentation of inflammatory arthritis: Observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.” Rheumatology 56(2): 231-238.

24) Ledingham, J. M., Snowden, N., Rivett, A., Galloway, J., Ide, Z., Firth, J., et al. (2017). “Achievement of NICE quality standards for patients with new presentation of inflammatory arthritis: Observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.” Rheumatology 56(2): 223-230.

25) Lu, R. S., Dennison, E., Denison, H., Cooper, C., Taylor, M. and Bottema, M. J. (2017). “Texture analysis based on Gabor filters improves the estimate of bone fracture risk from DXA images.” Comput Methods Biomech Biomed Eng Imaging Vis.

26) Lucas, R., Martins, A., Severo, M., Silva, P., Monjardino, T., Gaio, A. R., et al. (2017). “Quantitative modelling of hip fracture trends in 14 European countries: testing variations of a shared reversal over time.” Scientific Reports 7(1): 3754.

27) McCloskey, E. V., Johansson, H., Harvey, N. C., Compston, J. and Kanis, J. A. (2017). “Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.” Osteoporosis International 28(1): 71-76.

28) McCloskey, E. V., Johansson, H., Oden, A., Harvey, N. C., Jiang, H., Modin, S., et al. (2017). “The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study.” Journal of Bone & Mineral Research 05: 05.

29) Mikkola, T. M., von Bonsdorff, M. B., Osmond, C., Salonen, M. K., Kajantie, E., Cooper, C., et al. (2017). “Childhood growth predicts higher bone mass and greater bone area in early old age: findings among a subgroup of women from the Helsinki Birth Cohort Study.” Osteoporosis International.

30) Moon, R. J., Curtis, E. M., Davies, J. H., Cooper, C. and Harvey, N. C. (2017). “Seasonal variation in Internet searches for vitamin D.” Archives of Osteoporosis 12(1).

31) Moon, R. J., Harvey, N. C., Cooper, C., D’Angelo, S., Curtis, E. M., Crozier, S. R., et al. (2017). “Response to antenatal cholecalciferol supplementation is associated with common vitamin D related genetic variants.” Journal of Clinical Endocrinology & Metabolism 29: 29.

32) Ndosi, M., Ferguson, R., Backhouse, M. R., Bearne, L., Ainsworth, P., Roach, A., et al. (2017). “National variation in the composition of rheumatology multidisciplinary teams: a cross-sectional study.” Rheumatology International.

33) Nilsen, O. A., Ahmed, L. A., Winther, A., Christoffersen, T., Furberg, A. S., Grimnes, G., et al. (2017). “Changes and tracking of bone mineral density in late adolescence: the Tromso Study, Fit Futures.” Archives of Osteoporosis 12(1).

34) Povoroznyuk, V. V., Grygorieva, N. V., Kanis, J. A., McCloskey, E. V., Johansson, H., Harvey, N. C., et al. (2017). “Epidemiology of hip fracture and the development of FRAX in Ukraine.” Archives of Osteoporosis 12(1).

35) Pye, S. R., Ward, K. A., Cook, M. J., Laurent, M. R., Gielen, E., Borghs, H., et al. (2017). “Bone turnover predicts change in volumetric bone density and bone geometry at the radius in men.” Osteoporosis International 28(3): 935-944.

36) Rosengren, B. E., Bjork, J., Cooper, C. and Abrahamsen, B. (2017). “Recent hip fracture trends in Sweden and Denmark with age-period-cohort effects.” Osteoporosis International 28(1): 139-149.

37) Saengnipanthkul, S., Waikakul, S., Rojanasthien, S., Totemchokchyakarn, K., Srinkapaibulaya, A., Cheh Chin, T., et al. (2017). “Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment.” International Journal of Rheumatic Diseases 23: 23.

38) Shah, A., Prieto-Alhambra, D., Hawley, S., Delmestri, A., Lippett, J., Cooper, C., et al. (2017). “Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.” Osteoporosis International 28(1): 169-178.

39) Timmermans, E. J., van der Pas, S., Schaap, L. A., Cooper, C., Edwards, M. H., Gale, C. R., et al. (2017). “Associations between perceived neighbourhood problems and quality of life in older adults with and without osteoarthritis: Results from the Hertfordshire Cohort Study.” Health & Place 43: 144-150.

40) van der Velde, R. Y., Wyers, C. E., Teesselink, E., Geusens, P. P., van den Bergh, J. P., de Vries, F., et al. (2017). “Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicity.” Bone 94: 50-55.

41) Veronese, N., Stubbs, B., Crepaldi, G., Solmi, M., Cooper, C., Harvey, N. C. W., et al. (2017). “Relationship Between Low Bone Mineral Density and Fractures With Incident Cardiovascular Disease: A Systematic Review and Meta-Analysis.” Journal of Bone and Mineral Research 32(5): 1126-1135.

42) Veronese, N., Stubbs, B., Solmi, M., Smith, T. O., Noale, M., Cooper, C., et al. (2017). “Association between lower limb osteoarthritis and incidence of depressive symptoms: Data from the osteoarthritis initiative.” Age and Ageing 46(3): 470-476.

43) Ward, K. A., Jarjou, L. and Prentice, A. (2017). “Long-term effects of maternal calcium supplementation on childhood growth differ between males and females in a population accustomed to a low calcium intake.” Bone 103(pp 31-38).

44) Warner, S. C., Walsh, D. A., Laslett, L. L., Maciewicz, R. A., Soni, A., Hart, D. J., et al. (2017). “Pain in knee osteoarthritis is associated with variation in the neurokinin 1/substance P receptor (TACR1) gene.” European Journal of Pain.

45) Zengin, A., Pye, S. R., Cook, M. J., Adams, J. E., Rawer, R., Wu, F. C., et al. (2017). “Associations of muscle force, power, cross-sectional muscle area and bone geometry in older UK men.” Journal of Cachexia, Sarcopenia and Muscle.

2016

1) Arden, N. K., Cro, S., Sheard, S., Dore, C. J., Bara, A., Tebbs, S. A., et al. (2016). “The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial.” Osteoarthritis & Cartilage 24(11): 1858-1866.

2) Azagra, R., Zwart, M., Aguye, A., Martin-Sanchez, J. C., Casado, E., Diaz-Herrera, M. A., et al. (2016). “Fracture experience among participants from the FROCAT study: what thresholding is appropriate using the FRAX tool?” Maturitas 83: 65-71.

3) Bell, K., Clark, L., Fairhurst, C., Mitchell, N., Lenaghan, E., Blacklock, J., et al. (2016). “Enclosing a pen reduced time to response to questionnaire mailings.” J Clin Epidemiol 74: 144-150.

4) Bours, S., de Vries, F., van den Bergh, J. P., Lalmohamed, A., van Staa, T. P., Leufkens, H. G., et al. (2016). “Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.” Osteoporosis International 27(4): 1603-1610.

5) Bruyere, O., Beaudart, C., Reginster, J. Y., Buckinx, F., Schoene, D., Hirani, V., et al. (2016). “Assessment of muscle mass, muscle strength and physical performance in clinical practice: An international survey.” European Geriatric Medicine 7(3): 243-246.

6) Chakhtoura, M., Nassar, A., Arabi, A., Cooper, C., Harvey, N., Mahfoud, Z., et al. (2016). “Effect of vitamin D replacement on maternal and neonatal outcomes: a randomised controlled trial in pregnant women with hypovitaminosis D. A protocol.” BMJ Open 6(3): e010818.

7) Christoffersen, T., Ahmed, L. A., Winther, A., Nilsen, O. A., Furberg, A. S., Grimnes, G., et al. (2016). “Fracture incidence rates in Norwegian children, The Tromso Study, Fit Futures.” Archives of Osteoporosis 11(1): 40.

8) Cole, T. J., Kuh, D., Johnson, W., Ward, K. A., Howe, L. D., Adams, J. E., et al. (2016). “Using Super-Imposition by Translation And Rotation (SITAR) to relate pubertal growth to bone health in later life: the Medical Research Council (MRC) National Survey of Health and Development.” Int J Epidemiol 45(4): 1125-1134.

9) Compston, J. E., Wyman, A., FitzGerald, G., Adachi, J. D., Chapurlat, R. D., Cooper, C., et al. (2016). “Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women.” Journal of Bone & Mineral Research 31(7): 1466-1472.

10) Cook, M. J., Oldroyd, A., Pye, S. R., Ward, K. A., Gielen, E., Ravindrarajah, R., et al. (2016). “Frailty and bone health in European men.” Age Ageing.

11) Cooper, C., Harvey, N. C., Bishop, N. J., Kennedy, S., Papageorghiou, A. T., Schoenmakers, I., et al. (2016). “Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial.” The Lancet Diabetes & Endocrinology 4(5): 393-402.

12) Curtis, E. M., Harvey, N. C., D’Angelo, S., Cooper, C. S., Ward, K. A., Taylor, P., et al. (2016). “Bone mineral content and areal density, but not bone area, predict an incident fracture risk: a comparative study in a UK prospective cohort.” Archives of Osteoporosis 11(1): 39.

13) Curtis, E. M., van der Velde, R., Moon, R. J., van den Bergh, J. P., Geusens, P., de Vries, F., et al. (2016). “Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status.” Bone 87: 19-26.

14) Deere, K. C., Hannam, K., Coulson, J., Ireland, A., McPhee, J. S., Moss, C., et al. (2016). “Quantifying Habitual Levels of Physical Activity According to Impact in Older People: Accelerometry Protocol for the VIBE Study.” Journal of Aging & Physical Activity 24(2): 290-295.

15) Denison, H. J., Curtis, E. M., Clynes, M. A., Bromhead, C., Dennison, E. M. and Grainger, R. (2016). “The incidence of sexually acquired reactive arthritis: a systematic literature review.” Clinical Rheumatology 35(11): 2639-2648.

16) Drew, S., Judge, A., Cooper, C., Javaid, M. K., Farmer, A. and Gooberman-Hill, R. (2016). “Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.” Osteoporosis International 27(5): 1719-1727.

17) Edwards, M. H., Parsons, C., Bruyere, O., Petit Dop, F., Chapurlat, R., Roemer, F. W., et al. (2016). “High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study.” Journal of Rheumatology 43(3): 657-665.

18) Edwards, M. H., Robinson, D. E., Ward, K. A., Javaid, M. K., Walker-Bone, K., Cooper, C., et al. (2016). “Cluster analysis of bone microarchitecture from high resolution peripheral quantitative computed tomography demonstrates two separate phenotypes associated with high fracture risk in men and women.” Bone 88: 131-137.

19) Fina-Aviles, F., Medina-Peralta, M., Mendez-Boo, L., Hermosilla, E., Elorza, J. M., Garcia-Gil, M., et al. (2016). “The descriptive epidemiology of rheumatoid arthritis in Catalonia: a retrospective study using routinely collected data.” Clinical Rheumatology 35(3): 751-757.

20) Fong, W., Holroyd, C., Davidson, B., Armstrong, R., Harvey, N., Dennison, E., et al. (2016). “The effectiveness of a real life dose reduction strategy for tumour necrosis factor inhibitors in ankylosing spondylitis and psoriatic arthritis.” Rheumatology 55(10): 1837-1842.

21) Forestier-Zhang, L., Watts, L., Turner, A., Teare, H., Kaye, J., Barrett, J., et al. (2016). “Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia.” Orphanet Journal of Rare Diseases 11(1): 1-9.

22) Goulston, L. M., Sanchez-Santos, M. T., D’Angelo, S., Leyland, K. M., Hart, D. J., Spector, T. D., et al. (2016). “A comparison of radiographic anatomic axis knee alignment measurements and cross-sectional associations with knee osteoarthritis.” Osteoarthritis & Cartilage 24(4): 612-622.

23) Handel, M. N., Moon, R. J., Titcombe, P., Abrahamsen, B., Heitmann, B. L., Calder, P. C., et al. (2016). “Maternal serum retinol and beta-carotene concentrations and neonatal bone mineralization: results from the Southampton Women’s Survey cohort.” American Journal of Clinical Nutrition 104(4): 1183-1188.

24) Harvey, N. C., Johansson, H., Oden, A., Karlsson, M. K., Rosengren, B. E., Ljunggren, O., et al. (2016). “FRAX predicts incident falls in elderly men: findings from MrOs Sweden.” Osteoporosis International 27(1): 267-274.

25) Hawley, S., Javaid, M. K., Prieto-Alhambra, D., Lippett, J., Sheard, S., Arden, N. K., et al. (2016). “Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study.” Age & Ageing 45(2): 236-242.

26) Hawley, S., Javaid, M. K., Rubin, K. H., Judge, A., Arden, N. K., Vestergaard, P., et al. (2016). “Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study.” Journal of Bone & Mineral Research 31(1): 234-244.

27) Hawley, S., Leal, J., Delmestri, A., Prieto-Alhambra, D., Arden, N. K., Cooper, C., et al. (2016). “Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis.” Journal of Bone & Mineral Research 31(11): 2008-2015.

28) Herbolsheimer, F., Schaap, L. A., Edwards, M. H., Maggi, S., Otero, A., Timmermans, E. J., et al. (2016). “Physical Activity Patterns among Older Adults with and Without Knee Osteoarthritis in Six European Countries.” Arthritis Care and Research 68(2): 228-236.

29) Holroyd, C. R., Osmond, C., Barker, D. J., Ring, S. M., Lawlor, D. A., Tobias, J. H., et al. (2016). “Placental Size Is Associated Differentially With Postnatal Bone Size and Density.” Journal of Bone & Mineral Research 31(10): 1855-1864.

30) Javaid, M. K., Forestier-Zhang, L., Watts, L., Turner, A., Ponte, C., Teare, H., et al. (2016). “The RUDY study platform – a novel approach to patient driven research in rare musculoskeletal diseases.” Orphanet Journal of Rare Diseases 11(1): 1-9.

31) Jenkins, T., Coutts, L. V., D’Angelo, S., Dunlop, D. G., Oreffo, R. O., Cooper, C., et al. (2016). “Site-Dependent Reference Point Microindentation Complements Clinical Measures for Improved Fracture Risk Assessment at the Human Femoral Neck.” Journal of Bone & Mineral Research 31(1): 196-203.

32) Kanis, J. A., Harvey, N. C., Cooper, C., Johansson, H., Oden, A., McCloskey, E. V., et al. (2016). “A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.” Archives of Osteoporosis 11(1): 25.

33) Kluzek, S., Sanchez-Santos, M. T., Leyland, K. M., Judge, A., Spector, T. D., Hart, D., et al. (2016). “Painful knee but not hand osteoarthritis is an independent predictor of mortality over 23 years follow-up of a population-based cohort of middle-aged women.” Annals of the Rheumatic Diseases 75(10): 1749-1756.

34) Kuh, D., Muthuri, S., Cooper, R., Moore, A., Mackinnon, K., Cooper, C., et al. (2016). “Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60-64 Years: A British Birth Cohort.” Journal of Clinical Endocrinology & Metabolism 101(10): 3827-3837.

35) Kuh, D., Muthuri, S. G., Moore, A., Cole, T. J., Adams, J. E., Cooper, C., et al. (2016). “Pubertal timing and bone phenotype in early old age: findings from a British birth cohort study.” International Journal of Epidemiology 45(4): 1113-1124.

36) Lalmohamed, A., van Staa, T. P., Vestergaard, P., Leufkens, H. G., de Boer, A., Emans, P., et al. (2016). “Statins and Risk of Lower Limb Revision Surgery: The Influence of Differences in Study Design Using Electronic Health Records From the United Kingdom and Denmark.” American Journal of Epidemiology 184(1): 58-66.

37) Leal, J., Gray, A. M., Prieto-Alhambra, D., Arden, N. K., Cooper, C., Javaid, M. K., et al. (2016). “Impact of hip fracture on hospital care costs: a population-based study.” Osteoporosis International 27(2): 549-558.

38) Leyland, K. M., Judge, A., Javaid, M. K., Diez-Perez, A., Carr, A., Cooper, C., et al. (2016). “Obesity and the Relative Risk of Knee Replacement Surgery in Patients With Knee Osteoarthritis: A Prospective Cohort Study.” Arthritis & Rheumatology 68(4): 817-825.

39) Litwic, A. E., Clynes, M., Denison, H. J., Jameson, K. A., Edwards, M. H., Sayer, A. A., et al. (2016). “Non-invasive Assessment of Lower Limb Geometry and Strength Using Hip Structural Analysis and Peripheral Quantitative Computed Tomography: A Population-Based Comparison.” Calcified Tissue International 98(2): 158-164.

40) McCloskey, E. V., Oden, A., Harvey, N. C., Leslie, W. D., Hans, D., Johansson, H., et al. (2016). “A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX.” Journal of Bone & Mineral Research 31(5): 940-948.

41) Moon, R. J., Harvey, N. C., Cooper, C., D’Angelo, S., Crozier, S. R., Inskip, H. M., et al. (2016). “Determinants of the Maternal 25-Hydroxyvitamin D Response to Vitamin D Supplementation During Pregnancy.” Journal of Clinical Endocrinology & Metabolism 101(12): 5012-5020.

42) Moon, R. J., Harvey, N. C., Curtis, E. M., de Vries, F., van Staa, T. and Cooper, C. (2016). “Ethnic and geographic variations in the epidemiology of childhood fractures in the United Kingdom.” Bone 85: 9-14.

43) Moon, R. J., Lim, A., Farmer, M., Segaran, A., Clarke, N. M., Harvey, N. C., et al. (2016). “Validity of parental recall of children’s fracture: implications for investigation of childhood osteoporosis.” Osteoporosis International 27(2): 809-813.

44) Paccou, J., Edwards, M. H., Patsch, J. M., Jameson, K. A., Ward, K. A., Moss, C., et al. (2016). “Lower leg arterial calcification assessed by high-resolution peripheral quantitative computed tomography is associated with bone microstructure abnormalities in women.” Osteoporosis International 27(11): 3279-3287.

45) Paccou, J., Ward, K. A., Jameson, K. A., Dennison, E. M., Cooper, C. and Edwards, M. H. (2016). “Bone Microarchitecture in Men and Women with Diabetes: The Importance of Cortical Porosity.” Calcified Tissue International 98(5): 465-473.

46) Reyes, C., Leyland, K. M., Peat, G., Cooper, C., Arden, N. K. and Prieto-Alhambra, D. (2016). “Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis: A Population-Based Cohort Study.” Arthritis & Rheumatology 68(8): 1869-1875.

47) Reyes, C., Pottegard, A., Schwarz, P., Javaid, M. K., Van Staa, T. P., Cooper, C., et al. (2016). “Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion.” Calcified Tissue International 99(3): 243-249.

48) Robinson, P. C., Leo, P. J., Pointon, J. J., Harris, J., Cremin, K., Bradbury, L. A., et al. (2016). “The genetic associations of acute anterior uveitis and their overlap with the genetics of ankylosing spondylitis.” Genes and Immunity 17(1): 46-51.

49) Siviero, P., Zambon, S., Limongi, F., Castell, M. V., Cooper, C., Deeg, D. J., et al. (2016). “How Hand Osteoarthritis, Comorbidity, and Pain Interact to Determine Functional Limitation in Older People: Observations From the European Project on OSteoArthritis Study.” Arthritis & Rheumatology 68(11): 2662-2670.

50) Solis-Trapala, I., Schoenmakers, I., Goldberg, G. R., Prentice, A. and Ward, K. A. (2016). “Sequences of Regressions Distinguish Nonmechanical from Mechanical Associations between Metabolic Factors, Body Composition, and Bone in Healthy Postmenopausal Women.” J Nutr.

51) Timmermans, E. J., van der Pas, S., Cooper, C., Schaap, L. A., Edwards, M. H., Deeg, D. J., et al. (2016). “The neighbourhood environment and use of neighbourhood resources in older adults with and without lower limb osteoarthritis: results from the Hertfordshire Cohort Study.” Clinical Rheumatology 35(11): 2797-2805.

52) Timmermans, E. J., van der Pas, S., Dennison, E. M., Maggi, S., Peter, R., Castell, M. V., et al. (2016). “The Influence of Weather Conditions on Outdoor Physical Activity Among Older People With and Without Osteoarthritis in Six European Countries.” Journal of Physical Activity & Health 13: 1385-1395.

53) van der Pas, S., Schaap, L. A., Castell, M. V., Cooper, C., Denkinger, M., Edwards, M. H., et al. (2016). “Availability and use of neighborhood resources by older people with osteoarthritis: Results from the European Project on OSteoArthritis.” Health and Place 37: 1-7.

54) van der Velde, R. Y., Wyers, C. E., Curtis, E. M., Geusens, P. P., van den Bergh, J. P., de Vries, F., et al. (2016). “Secular trends in fracture incidence in the UK between 1990 and 2012.” Osteoporosis International 27(11): 3197-3206.

55) van Schoor, N. M., Zambon, S., Castell, M. V., Cooper, C., Denkinger, M., Dennison, E. M., et al. (2016). “Impact of clinical osteoarthritis of the hip, knee and hand on self-rated health in six European countries: the European Project on OSteoArthritis.” Quality of Life Research 25(6): 1423-1432.

56) Veronese, N., Stubbs, B., Noale, M., Solmi, M., Luchini, C., Smith, T. O., et al. (2016). “Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: Data from the osteoarthritis initiative.” Clinical Nutrition 8: 8.

57) Vogel, C., Parsons, C., Godfrey, K., Robinson, S., Harvey, N. C., Inskip, H., et al. (2016). “Greater access to fast-food outlets is associated with poorer bone health in young children.” Osteoporosis International 27(3): 1011-1019.

58) Walker-Bone, K., Harvey, N. C., Ntani, G., Tinati, T., Jones, G. T., Smith, B. H., et al. (2016). “Chronic widespread bodily pain is increased among individuals with history of fracture: findings from UK Biobank.” Archives of Osteoporosis 11: 1.

59) Zambon, S., Siviero, P., Denkinger, M., Limongi, F., Castell, M. V., Van Der Pas, S., et al. (2016). “Role of Osteoarthritis, Comorbidity, and Pain in Determining Functional Limitations in Older Populations: European Project on OSteoArthritis.” Arthritis Care and Research 68(6): 801-810.

60) Zengin, A., Pye, S. R., Cook, M. J., Adams, J. E., Wu, F. C., O’Neill, T. W., et al. (2016). “Ethnic differences in bone geometry between White, Black and South Asian men in the UK.” Bone 91: 180-185.

61) Zhang, J., Jameson, K., Sayer, A. A., Robinson, S., Cooper, C. and Dennison, E. (2016). “Accumulation of risk factors associated with poor bone health in older adults.” Archives of Osteoporosis 11: 3.

2015

1) Abrahamsen, B., Osmond, C. and Cooper, C. (2015). “Life Expectancy in Patients Treated for Osteoporosis: Observational Cohort Study Using National Danish Prescription Data.” J Bone Miner Res 30(9): 1553-1559.

2) Armbrecht, G., Felsenberg, D., Ganswindt, M., Lunt, M., Kaptoge, S. K., Abendroth, K., et al. (2015). “Vertebral Scheuermann’s disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.” Osteoporosis International 26(10): 2509-2519.

4) Bishop, F. L., Yardley, L., Prescott, P., Cooper, C., Little, P. and Lewith, G. T. (2015). “Psychological covariates of longitudinal changes in back-related disability in patients undergoing acupuncture.” Clinical Journal of Pain 31(3): 254-264.

5) Carbonell-Abella, C., Pages-Castella, A., Javaid, M. K., Nogues, X., Farmer, A. J., Cooper, C., et al. (2015). “Early (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study.” Calcified Tissue International 97(6): 535-541.

6) Castell, M. V., van der Pas, S., Otero, A., Siviero, P., Dennison, E., Denkinger, M., et al. (2015). “Osteoarthritis and frailty in elderly individuals across six European countries: results from the European Project on OSteoArthritis (EPOSA).” BMC Musculoskeletal Disorders 16: 359.

7) Christoffersen, T., Winther, A., Nilsen, O. A., Ahmed, L. A., Furberg, A. S., Grimnes, G., et al. (2015). “Does the frequency and intensity of physical activity in adolescence have an impact on bone? The Tromso Study, Fit Futures.” BMC Sports Science, Medicine and Rehabilitation 7: 26.

8) Cleal, J. K., Day, P. E., Simner, C. L., Barton, S. J., Mahon, P. A., Inskip, H. M., et al. (2015). “Placental amino acid transport may be regulated by maternal vitamin D and vitamin D-binding protein: results from the Southampton Women’s Survey.” British Journal of Nutrition 113(12): 1903-1910.

9) Clynes, M. A., Edwards, M. H., Buehring, B., Dennison, E. M., Binkley, N. and Cooper, C. (2015). “Definitions of Sarcopenia: Associations with Previous Falls and Fracture in a Population Sample.” Calcified Tissue International 97(5): 445-452.

10) Colebatch-Bourn, A. N., Conaghan, P. G., Arden, N. K., Cooper, C., Dougados, M. and Edwards, C. J. (2015). “Raising the quality of rheumatology management recommendations: lessons from the EULAR process 10 years after provision of standard operating procedures.” Rheumatology 54(8): 1392-1396.

11) Coutts, L. V., Jenkins, T., Li, T., Dunlop, D. G., Oreffo, R. O., Cooper, C., et al. (2015). “Variability in reference point microindentation and recommendations for testing cortical bone: location, thickness and orientation heterogeneity.” Journal of the Mechanical Behavior of Biomedical Materials 46: 292-304.

12) Culliford, D., Maskell, J., Judge, A., Cooper, C., Prieto-Alhambra, D., Arden, N. K., et al. (2015). “Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink.” Osteoarthritis & Cartilage 23(4): 594-600.

13) Davey, T., Lanham-New, S. A., Shaw, A. M., Cobley, R., Allsopp, A. J., Hajjawi, M. O., et al. (2015). “Fundamental differences in axial and appendicular bone density in stress fractured and uninjured Royal Marine recruits–a matched case-control study.” Bone 73: 120-126.

14) Day, P. E., Ntani, G., Crozier, S. R., Mahon, P. A., Inskip, H. M., Cooper, C., et al. (2015). “Maternal Factors Are Associated with the Expression of Placental Genes Involved in Amino Acid Metabolism and Transport.” PLoS One 10(12): e0143653.

15) Dennison, E. M., Rubin, K. H., Schwarz, P., Harvey, N. C., Bone, K. W., Cooper, C., et al. (2015). “Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study.” Arch Osteoporos 10: 36.

16) Di Angelantonio, E., Kaptoge, S., Wormser, D., Willeit, P., Butterworth, A. S., Bansal, N., et al. (2015). “Association of Cardiometabolic Multimorbidity With Mortality.” Jama 314(1): 52-60.

17) Drew, S., Gooberman-Hill, R., Farmer, A., Graham, L., Javaid, M. K., Cooper, C., et al. (2015). “Making the case for a fracture liaison service: a qualitative study of the experiences of clinicians and service managers.” BMC Musculoskeletal Disorders 16: 274.

18) Drew, S., Judge, A., May, C., Farmer, A., Cooper, C., Javaid, M. K., et al. (2015). “Implementation of secondary fracture prevention services after hip fracture: a qualitative study using extended Normalization Process Theory.” Implementation Science 10: 57.

19) Edwards, M. H., Ward, K. A., Ntani, G., Parsons, C., Thompson, J., Sayer, A. A., et al. (2015). “Lean mass and fat mass have differing associations with bone microarchitecture assessed by high resolution peripheral quantitative computed tomography in men and women from the Hertfordshire Cohort Study.” Bone 81: 145-151.

20) Eymard, F., Parsons, C., Edwards, M. H., Petit-Dop, F., Reginster, J. Y., Bruyere, O., et al. (2015). “Diabetes is a risk factor for knee osteoarthritis progression.” Osteoarthritis & Cartilage 23(6): 851-859.

21) Gielen, E., O’Neill, T., Pye, S., Adams, J., Ward, K., Wu, F., et al. (2015). “Bone turnover markers predict hip bone loss in elderly European men: results of the European Male Ageing Study (EMAS).” Osteoporosis International 26(2): 617-627.

22) Hardcastle, S. A., Dieppe, P., Gregson, C. L., Arden, N. K., Spector, T. D., Hart, D. J., et al. (2015). “Individuals with high bone mass have an increased prevalence of radiographic knee osteoarthritis.” Bone 71: 171-179.

23) Harvey, N. C., Kanis, J. A., Oden, A., Burge, R. T., Mitlak, B. H., Johansson, H., et al. (2015). “FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.” Osteoporosis International 26(11): 2677-2684.

24) Harvey, N. C., Kanis, J. A., Oden, A., Nakamura, T., Shiraki, M., Sugimoto, T., et al. (2015). “Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX.” Osteoporosis International 26(9): 2347-2353.

25) Javaid, M. K., Kyer, C., Mitchell, P. J., Chana, J., Moss, C., Edwards, M. H., et al. (2015). “Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture Best Practice Framework tool.” Osteoporosis International 26(11): 2573-2578.

26) Jenkins, T., Coutts, L. V., Dunlop, D. G., Oreffo, R. O., Cooper, C., Harvey, N. C., et al. (2015). “Variability in reference point microindentation and recommendations for testing cortical bone: maximum load, sample orientation, mode of use, sample preparation and measurement spacing.” J Mech Behav Biomed Mater 42: 311-324.

27) Johansson, H., Oden, A., Lorentzon, M., McCloskey, E., Kanis, J. A., Harvey, N. C., et al. (2015). “Is the Swedish FRAX model appropriate for Swedish immigrants?” Osteoporosis International 26(11): 2617-2622.

28) Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O’Ryan, F., et al. (2015). “Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.” Journal of Bone & Mineral Research 30(1): 3-23.

29) Kiran, A., Bottomley, N., Biant, L. C., Javaid, M. K., Carr, A. J., Cooper, C., et al. (2015). “Variations In Good Patient Reported Outcomes After Total Knee Arthroplasty.” Journal of Arthroplasty 30(8): 1364-1371.

30) Klop, C., Gibson-Smith, D., Elders, P. J., Welsing, P. M., Leufkens, H. G., Harvey, N. C., et al. (2015). “Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.” Osteoporosis International 26(7): 1919-1928.

31) Mansour, S., Tocheva, A. S., Sanderson, J. P., Goulston, L. M., Platten, H., Serhal, L., et al. (2015). “Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid Arthritis.” J Immunol 195(12): 5582-5591.

32) Marks, J. L., Holroyd, C. R., Dimitrov, B. D., Armstrong, R. D., Calogeras, A., Cooper, C., et al. (2015). “Does combined clinical and ultrasound assessment allow selection of individuals with rheumatoid arthritis for sustained reduction of anti-tumor necrosis factor therapy?” Arthritis Care Res (Hoboken) 67(6): 746-753.

33) Martinez-Laguna, D., Tebe, C., Javaid, M. K., Nogues, X., Arden, N. K., Cooper, C., et al. (2015). “Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study.” Osteoporosis International 26(2): 827-833.

34) McCloskey, E., Kanis, J. A., Johansson, H., Harvey, N., Oden, A., Cooper, A., et al. (2015). “FRAX-based assessment and intervention thresholds–an exploration of thresholds in women aged 50 years and older in the UK.” Osteoporosis International 26(8): 2091-2099.

35) McCloskey, E. V., Kanis, J. A., Oden, A., Harvey, N. C., Bauer, D., Gonzalez-Macias, J., et al. (2015). “Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis.” Osteoporosis International 26(7): 1979-1987.

36) McCloskey, E. V., Oden, A., Harvey, N. C., Leslie, W. D., Hans, D., Johansson, H., et al. (2015). “Adjusting fracture probability by trabecular bone score.” Calcified Tissue International 96(6): 500-509.

37) Menni, C., Graham, D., Kastenmuller, G., Alharbi, N. H., Alsanosi, S. M., McBride, M., et al. (2015). “Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate.” Hypertension 66(2): 422-429.

38) Moon, R. J., Cole, Z. A., Crozier, S. R., Curtis, E. M., Davies, J. H., Gregson, C. L., et al. (2015). “Longitudinal changes in lean mass predict pQCT measures of tibial geometry and mineralisation at 6-7 years.” Bone 75: 105-110.

39) Moon, R. J., Crozier, S. R., Dennison, E. M., Davies, J. H., Robinson, S. M., Inskip, H. M., et al. (2015). “Tracking of 25-hydroxyvitamin D status during pregnancy: the importance of vitamin D supplementation.” Am J Clin Nutr 102(5): 1081-1087.

40) Moon, R. J., Lim, A., Farmer, M., Segaran, A., Clarke, N. M., Dennison, E. M., et al. (2015). “Differences in childhood adiposity influence upper limb fracture site.” Bone 79: 88-93.

41) Oden, A., McCloskey, E. V., Kanis, J. A., Harvey, N. C. and Johansson, H. (2015). “Burden of high fracture probability worldwide: secular increases 2010-2040.” Osteoporosis International 26(9): 2243-2248.

42) Paccou, J., Edwards, M. H., Ward, K., Jameson, K., Moon, R., Dennison, E., et al. (2015). “Relationships between bone geometry, volumetric bone mineral density and bone microarchitecture of the distal radius and tibia with alcohol consumption.” Bone 78: 122-129.

43) Paccou, J., Edwards, M. H., Ward, K. A., Jameson, K. A., Moss, C. L., Harvey, N. C., et al. (2015). “Ischemic heart disease is associated with lower cortical volumetric bone mineral density of distal radius.” Osteoporos Int 26(7): 1893-1901.

44) Parsons, C., Clynes, M., Syddall, H., Jagannath, D., Litwic, A., van der Pas, S., et al. (2015). “How well do radiographic, clinical and self-reported diagnoses of knee osteoarthritis agree? Findings from the Hertfordshire cohort study.” Springerplus 4: 177.

45) Prieto-Alhambra, D., Javaid, M. K., Judge, A., Maskell, J., Cooper, C., Arden, N. K., et al. (2015). “Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study.” Ann Rheum Dis 74(3): 557-563.

46) Prieto-Alhambra, D., Munoz-Ortego, J., De Vries, F., Vosse, D., Arden, N. K., Bowness, P., et al. (2015). “Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study.” Osteoporosis International 26(1): 85-91.

47) Reppe, S., Wang, Y., Thompson, W. K., McEvoy, L. K., Schork, A. J., Zuber, V., et al. (2015). “Genetic sharing with cardiovascular disease risk factors and diabetes reveals novel bone mineral density loci.” PLoS ONE 10 (12) (no pagination)(e0144531).

48) Reyes, C., Garcia-Gil, M., Elorza, J. M., Mendez-Boo, L., Hermosilla, E., Javaid, M. K., et al. (2015). “Socio-economic status and the risk of developing hand, hip or knee osteoarthritis: a region-wide ecological study.” Osteoarthritis & Cartilage 23(8): 1323-1329.

49) Rice, S. A., Carpenter, M., Fityan, A., Vearncombe, L. M., Ardern-Jones, M., Jackson, A. A., et al. (2015). “Limited exposure to ambient ultraviolet radiation and 25-hydroxyvitamin D levels: a systematic review.” British Journal of Dermatology 172(3): 652-661.

50) Timmermans, E. J., Schaap, L. A., Herbolsheimer, F., Dennison, E. M., Maggi, S., Pedersen, N. L., et al. (2015). “The Influence of Weather Conditions on Joint Pain in Older People with Osteoarthritis: Results from the European Project on OSteoArthritis.” Journal of Rheumatology 42(10): 1885-1892.

51) Wijnands, J. M., van Durme, C. M., Driessen, J. H., Boonen, A., Klop, C., Leufkens, B., et al. (2015). “Individuals With Type 2 Diabetes Mellitus Are at an Increased Risk of Gout But This Is Not Due to Diabetes: A Population-Based Cohort Study.” Medicine 94(32): e1358.

52) Wilson, N., Sanchez-Riera, L., Morros, R., Diez-Perez, A., Javaid, M. K., Cooper, C., et al. (2015). “Drug utilization in patients with OA: a population-based study.” Rheumatology 54(5): 860-867.

53) Winther, A., Ahmed, L. A., Furberg, A. S., Grimnes, G., Jorde, R., Nilsen, O. A., et al. (2015). “Leisure time computer use and adolescent bone health-findings from the Tromso Study, Fit Futures: A cross-sectional study.” BMJ Open 5 (6) (no pagination)(e006665).

54) Zambon, S., Siviero, P., Denkinger, M., Limongi, F., Castell, M. V., van der Pas, S., et al. (2015). “Osteoarthritis, comorbidity and pain: Their role in determining functional limitations in older populations (European project on Osteoarthritis).” Arthritis Care Res (Hoboken).

2014

1) Adams, J. E., Engelke, K., Zemel, B. S. and Ward, K. A. (2014). “Quantitative computer tomography in children and adolescents: the 2013 ISCD Pediatric Official Positions.” J Clin Densitom 17(2): 258-274.

2) Azagra, R., Lopez-Exposito, F., Martin-Sanchez, J. C., Aguye, A., Moreno, N., Cooper, C., et al. (2014). “Changing trends in the epidemiology of hip fracture in Spain.” Osteoporosis International 25(4): 1267-1274.

3) Bruyere, O., Reginster, J. Y., Bellamy, N., Chapurlat, R., Richette, P., Cooper, C., et al. (2014). “Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.” Rheumatology 53(8): 1457-1464.

4) Bultink, I. E., Harvey, N. C., Lalmohamed, A., Cooper, C., Lems, W. F., van Staa, T. P., et al. (2014). “Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom.” Osteoporosis International 25(4): 1275-1283.

5) Clynes, M. A., Parsons, C., Edwards, M. H., Jameson, K. A., Harvey, N. C., Sayer, A. A., et al. (2014). “Further evidence of the developmental origins of osteoarthritis: results from the Hertfordshire Cohort Study.” Journal of Developmental Origins of Health and Disease 5(6): 453-458.

6) Clynes, M. A., Wyawahare, P., Robinson, G., Denison, H. J., Evans, G., Gilmour, M., et al. (2014). “Bone health among premenopausal female alcoholics: A pilot study.” Open Bone Journal 7(1): 14-18.

7) Compston, J. E., Flahive, J., Hooven, F. H., Anderson, F. A., Jr., Adachi, J. D., Boonen, S., et al. (2014). “Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW).” Calcified Tissue International 94(2): 223-231.

8) Compston, J. E., Flahive, J., Hosmer, D. W., Watts, N. B., Siris, E. S., Silverman, S., et al. (2014). “Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).” Journal of Bone & Mineral Research 29(2): 487-493.

9) Cooper, C., Fox, K. M. and Borer, J. S. (2014). “Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case-control study in the CPRD.” Osteoporosis International 25(2): 737-745.

10) Cousminer, D. L., Stergiakouli, E., Berry, D. J., Ang, W., Groen-Blokhuis, M. M., Korner, A., et al. (2014). “Genome-wide association study of sexual maturation in males and females highlights a role for body mass and menarche loci in male puberty.” Hum Mol Genet 23(16): 4452-4464.

11) Dennison, E. M., Jameson, K. A., Edwards, M. H., Denison, H. J., Aihie Sayer, A. and Cooper, C. (2014). “Peripheral quantitative computed tomography measures are associated with adult fracture risk: the Hertfordshire Cohort Study.” Bone 64: 13-17.

12) Diez-Perez, A., Adachi, J. D., Adami, S., Anderson, F. A., Jr., Boonen, S., Chapurlat, R., et al. (2014). “Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).” Journal of Bone & Mineral Research 29(1): 260-267.

13) Drew, S., Sheard, S., Chana, J., Cooper, C., Javaid, M. K., Judge, A., et al. (2014). “Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England.” Osteoporosis International 25(10): 2427-2433.

14) Edwards, M. H., van der Pas, S., Denkinger, M. D., Parsons, C., Jameson, K. A., Schaap, L., et al. (2014). “Relationships between physical performance and knee and hip osteoarthritis: findings from the European Project on Osteoarthritis (EPOSA).” Age & Ageing 43(6): 806-813.

15) FitzGerald, G., Compston, J. E., Chapurlat, R. D., Pfeilschifter, J., Cooper, C., Hosmer, D. W., Jr., et al. (2014). “Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).” Journal of Clinical Endocrinology & Metabolism 99(3): 817-826.

16) Ford, J. A., MacLennan, G. S., Avenell, A., Bolland, M., Grey, A., Witham, M., et al. (2014). “Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis.” American Journal of Clinical Nutrition 100(3): 746-755.

17) Gibson-Smith, D., Klop, C., Elders, P., Wesling, P. M. J., van Schoor, N., Leufkens, H. G. M., et al. (2014). “The risk of major (non-hip) fragility fracture after hip fracture in the UK: 2000-2010.” Osteoporosis International 25: S663-S663.

18) Gregson, C. L., Dennison, E. M., Compston, J. E., Adami, S., Adachi, J. D., Anderson, F. A., Jr., et al. (2014). “Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.” Osteoporosis International 25(1): 85-95.

19) Hardcastle, S. A., Dieppe, P., Gregson, C. L., Arden, N. K., Spector, T. D., Hart, D. J., et al. (2014). “Osteophytes, enthesophytes, and high bone mass: a bone-forming triad with potential relevance in osteoarthritis.” Arthritis & Rheumatology 66(9): 2429-2439.

20) Hardcastle, S. A., Dieppe, P., Gregson, C. L., Hunter, D., Thomas, G. E., Arden, N. K., et al. (2014). “Prevalence of radiographic hip osteoarthritis is increased in high bone mass.” Osteoarthritis & Cartilage 22(8): 1120-1128.

21) Hardcastle, S. A., Gregson, C. L., Rittweger, J., Crabtree, N., Ward, K. and Tobias, J. H. (2014). “Jump power and force have distinct associations with cortical bone parameters: findings from a population enriched by individuals with high bone mass.” J Clin Endocrinol Metab 99(1): 266-275.

22) Harvey, N. C., Holroyd, C., Ntani, G., Javaid, K., Cooper, P., Moon, R., et al. (2014). “Vitamin D supplementation in pregnancy: a systematic review.” Health Technology Assessment (Winchester, England) 18(45): 1-190.

23) Harvey, N. C., Moon, R. J., Sayer, A. A., Ntani, G., Davies, J. H., Javaid, M. K., et al. (2014). “Maternal antenatal vitamin D status and offspring muscle development: findings from the Southampton Women’s Survey.” Journal of Clinical Endocrinology & Metabolism 99(1): 330-337.

24) Harvey, N. C., Sheppard, A., Godfrey, K. M., McLean, C., Garratt, E., Ntani, G., et al. (2014). “Childhood bone mineral content is associated with methylation status of the RXRA promoter at birth.” Journal of Bone & Mineral Research 29(3): 600-607.

25) Hiligsmann, M., Dellaert, B., Dirksen, C., Van d, W., Watson, V., Goemaere, S., et al. (2014). “Are Patients’ Preferences Transferable Between Countries? A Cross-European Discrete-Choice Experiment to Elicit Patients’ Preferences for Osteoporosis Drug Treatment.” Value in Health 17(7): A385.

26) Johansson, H., Oden, A., Kanis, J. A., McCloskey, E. V., Morris, H. A., Cooper, C., et al. (2014). “A meta-analysis of reference markers of bone turnover for prediction of fracture.” Calcified Tissue International 94(5): 560-567.

27) Jones, L. E., Roberts, L. C., Little, P. S., Mullee, M. A., Cleland, J. A. and Cooper, C. (2014). “Shared decision-making in back pain consultations: an illusion or reality?” European Spine Journal 23 Suppl 1: S13-19.

28) Judge, A., Batra, R. N., Thomas, G. E., Beard, D., Javaid, M. K., Murray, D. W., et al. (2014). “Body mass index is not a clinically meaningful predictor of patient reported outcomes of primary hip replacement surgery: prospective cohort study.” Osteoarthritis & Cartilage 22(3): 431-439.

29) Kanis, J. A., Johansson, H., Oden, A., Cooper, C., McCloskey, E. V. and Epidemiology and Quality of Life Working Group of IOF (2014). “Worldwide uptake of FRAX.” Archives of Osteoporosis 9: 166.

30) Kerr, E., Middleton, A., Churchill, D., Reading, I. and Walker-Bone, K. (2014). “A case-control study of elective hip surgery among HIV-infected patients: exposure to systemic glucocorticoids significantly increases the risk.” HIV Medicine 15(3): 182-188.

31) Kiran, A., Hunter, D. J., Judge, A., Field, R. E., Javaid, M. K., Cooper, C., et al. (2014). “A novel methodological approach for measuring symptomatic change following total joint arthroplasty.” Journal of Arthroplasty 29(11): 2140-2145.

32) Klop, C., Welsing, P. M., Cooper, C., Harvey, N. C., Elders, P. J., Bijlsma, J. W., et al. (2014). “Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study.” Bone 66: 171-177.

33) Kuh, D., Wills, A. K., Shah, I., Prentice, A., Hardy, R., Adams, J. E., et al. (2014). “Growth from birth to adulthood and bone phenotype in early old age: a British birth cohort study.” Journal of Bone & Mineral Research 29(1): 123-133.

34) Mathews, R. J., Robinson, J. I., Battellino, M., Wong, C., Taylor, J. C., Eyre, S., et al. (2014). “Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment.” Ann Rheum Dis 73(6): 1202-1210.

35) Moayyeri, A., Hsu, Y. H., Karasik, D., Estrada, K., Xiao, S. M., Nielson, C., et al. (2014). “Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium.” Human Molecular Genetics 23(11): 3054-3068.

36) Moon, R. J., Gilbert, R. D., Page, A., Murphy, L., Taylor, P., Cooper, C., et al. (2014). “Children with nephrotic syndrome have greater bone area but similar volumetric bone mineral density to healthy controls.” Bone 58: 108-113.

37) Munoz-Ortego, J., Vestergaard, P., Rubio, J. B., Wordsworth, P., Judge, A., Javaid, M. K., et al. (2014). “Ankylosing spondylitis is associated with an increased risk of vertebral and nonvertebral clinical fractures: a population-based cohort study.” J Bone Miner Res 29: 1770-1776.

38) Neogi, T., Soni, A., Doherty, S. A., Laslett, L. L., Maciewicz, R. A., Hart, D. J., et al. (2014). “Contribution of the COMT Val158Met variant to symptomatic knee osteoarthritis.” Annals of the Rheumatic Diseases 73(1): 315-317.

39) Oei, L., Hsu, Y. H., Styrkarsdottir, U., Eussen, B. H., de Klein, A., Peters, M. J., et al. (2014). “A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus.” Journal of Medical Genetics 51(2): 122-131.

40) Panoutsopoulou, K., Metrustry, S., Doherty, S. A., Laslett, L. L., Maciewicz, R. A., Hart, D. J., et al. (2014). “The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a Mendelian randomisation study.” Annals of the Rheumatic Diseases 73(12): 2082-2086.

41) Piscitelli, P., Brandi, M., Cawston, H., Gauthier, A., Kanis, J. A., Compston, J., et al. (2014). “Epidemiological burden of postmenopausal osteoporosis in Italy from 2010 to 2020: estimations from a disease model.” Calcified Tissue International 95(5): 419-427.

42) Pouwels, S., de Boer, A., Leufkens, H. G., Weber, W. E., Cooper, C. and de Vries, F. (2014). “Risk of fracture in patients with Charcot-Marie-Tooth disease.” Muscle & Nerve 50(6): 919-924.

43) Pouwels, S., de Boer, A., Leufkens, H. G., Weber, W. E., Cooper, C., van Onzenoort, H. A., et al. (2014). “Risk of fracture in patients with muscular dystrophies.” Osteoporosis International 25(2): 509-518.

44) Prieto-Alhambra, D., Guerri-Fernandez, R., De Vries, F., Lalmohamed, A., Bazelier, M., Starup-Linde, J., et al. (2014). “HIV infection and its association with an excess risk of clinical fractures: a nationwide case-control study.” Journal of Acquired Immune Deficiency Syndromes: JAIDS 66(1): 90-95.

45) Prieto-Alhambra, D., Judge, A., Arden, N. K., Cooper, C., Lyles, K. W. and Javaid, M. K. (2014). “Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.” Osteoporosis International 25(1): 77-83.

46) Prieto-Alhambra, D., Judge, A., Javaid, M. K., Cooper, C., Diez-Perez, A. and Arden, N. K. (2014). “Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints.” Annals of the Rheumatic Diseases 73(9): 1659-1664.

47) Prieto-Alhambra, D., Pages-Castella, A., Wallace, G., Javaid, M. K., Judge, A., Nogues, X., et al. (2014). “Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.” Journal of Bone & Mineral Research 29(1): 268-274.

48) Prieto-Alhambra, D., Petri, H., Goldenberg, J. S., Khong, T. P., Klungel, O. H., Robinson, N. J., et al. (2014). “Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA.” Osteoporosis International 25: 847-855.

49) Prieto-Alhambra, D., Premaor, M. O., Aviles, F. F., Castro, A. S., Javaid, M. K., Nogues, X., et al. (2014). “Relationship between mortality and BMI after fracture: a population-based study of men and women aged >40 years.” Journal of Bone & Mineral Research 29(8): 1737-1744.

50) Reyes, C., Estrada, P., Nogues, X., Orozco, P., Cooper, C., Diez-Perez, A., et al. (2014). “The impact of common co-morbidities (as measured using the Charlson index) on hip fracture risk in elderly men: a population-based cohort study.[Erratum appears in Osteoporos Int. 2014 Sep;25(9):2333 Note: Macias, J G [corrected to Gonzalez-Macias, J]].” Osteoporosis International 25(6): 1751-1758.

51) Short, C. E., Shaw, S. G., Fisher, M. J., Gilleece, Y. C. and Walker-Bone, K. (2014). “Comparison of peripheral forearm DXA and clinical risk factor screening using FRAX(R) to assess the risk of HIV-associated low bone mass: a cross-sectional study.” Arch Osteoporos 9: 181.

52) Short, C. E., Shaw, S. G., Fisher, M. J., Walker-Bone, K. and Gilleece, Y. C. (2014). “Prevalence of and risk factors for osteoporosis and fracture among a male HIV-infected population in the UK.” Int J STD AIDS 25(2): 113-121.

53) Timmermans, E. J., van der Pas, S., Schaap, L. A., Sanchez-Martinez, M., Zambon, S., Peter, R., et al. (2014). “Self-perceived weather sensitivity and joint pain in older people with osteoarthritis in six European countries: results from the European Project on OSteoArthritis (EPOSA).” BMC Musculoskelet Disord 15: 66.

54) Walker-Bone, K., D’Angelo, S., Syddall, H. E., Palmer, K. T., Cooper, C., Coggon, D., et al. (2014). “Exposure to heavy physical occupational activities during working life and bone mineral density at the hip at retirement age.” Occupational & Environmental Medicine 71(5): 329-331.

55) Wallace, G., Judge, A., Prieto-Alhambra, D., de Vries, F., Arden, N. K. and Cooper, C. (2014). “The effect of body mass index on the risk of post-operative complications during the 6 months following total hip replacement or total knee replacement surgery.” Osteoarthritis & Cartilage 22(7): 918-927.

56) Ward, K. A., Cole, T. J., Laskey, M. A., Ceesay, M., Mendy, M. B., Sawo, Y., et al. (2014). “The effect of prepubertal calcium carbonate supplementation on skeletal development in Gambian boys-a 12-year follow-up study.” J Clin Endocrinol Metab 99(9): 3169-3176.

57) Winther, A., Dennison, E., Ahmed, L. A., Furberg, A. S., Grimnes, G., Jorde, R., et al. (2014). “The Tromso Study: Fit Futures: a study of Norwegian adolescents’ lifestyle and bone health.” Arch Osteoporos. 9: 185.

58) Yaqub, M., Javaid, M. K., Cooper, C. and Noble, J. A. (2014). “Investigation of the role of feature selection and weighted voting in random forests for 3-D volumetric segmentation.” IEEE Trans Med Imaging 33(2): 258-271.

59) Zhang, L., Choi, H. J., Estrada, K., Leo, P. J., Li, J., Pei, Y. F., et al. (2014). “Multistage genome-wide association meta-analyses identified two new loci for bone mineral density.” Human Molecular Genetics 23: 1923-1933.

2013

1) Abrahamsen, B. and Harvey, N. C. (2013). “The role of vitamin D supplementation in patients with rheumatic diseases.” Nat.Rev.Rheumatol. 9: 411-422.

2) Agricola, R., Waarsing, J. H., Arden, N. K., Carr, A. J., Bierma-Zeinstra, S. M., Thomas, G. E., et al. (2013). “Cam impingement of the hip–a risk factor for hip osteoarthritis.” Nat.Rev.Rheumatol. 9: 630-634.

3) Akesson, K., Marsh, D., Mitchell, P. J., McLellan, A. R., Stenmark, J., Pierroz, D. D., et al. (2013). “Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle.” Osteoporos.Int. 24: 2135-2152.

4) Alfred, T., Ben-Shlomo, Y., Cooper, R., Hardy, R., Cooper, C., Deary, I. J., et al. (2013). “Genetic markers of bone and joint health and physical capability in older adults: the HALCyon programme.” Bone 52: 278-285.

5) Arden, N. K. and Leyland, K. M. (2013). “Osteoarthritis year 2013 in review: clinical.” Osteoarthritis.Cartilage. 21: 1409-1413.

6) Bazelier, M. T., de Vries, F., Vestergaard, P., Herings, R. M., Gallagher, A. M., Leufkens, H. G., et al. (2013). “Risk of fracture with thiazolidinediones: an individual patient data meta-analysis.” Front Endocrinol.(Lausanne) 4: 11.

7) Bazelier, M. T., van Staa, T. P., Bentzen, J., Vestergaard, P., Uitdehaag, B. M. J., Leufkens, H. G. M., et al. (2013). “Multiple sclerosis and fracture risk: traditional meta-analysis versus mega-analysis of individual patient data.” OE Epidemiology 1: 9.

8) Bruyere, O., Cooper, C., Pavelka, K., Rabenda, V., Buckinx, F., Beaudart, C., et al. (2013). “Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years.” Calcif.Tissue Int. 93: 502-507.

9) Compston, J., Bowring, C., Cooper, A., Cooper, C., Davies, C., Francis, R., et al. (2013). “Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.” Maturitas 75: 392-396.

10) Cooper, C., Adachi, J. D., Bardin, T., Berenbaum, F., Flamion, B., Jonsson, H., et al. (2013). “How to define responders in osteoarthritis.” Curr.Med.Res.Opin. 29: 719-729.

11) Cooper, C., Dennison, E., Edwards, M. H. and Litwic, A. (2013). “Epidemiology of osteoarthritis.” Medicographia 35: 145-151.

12) Costa, A. G., Wyman, A., Siris, E. S., Watts, N. B., Silverman, S., Saag, K. G., et al. (2013). “When, Where and How Osteoporosis-Associated Fractures Occur: An Analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW).” PLoS.One. 8: e83306.

13) Culliford, D., Maskell, J., Judge, A., Arden, N. K. and including Cooper, C. (2013). “A population-based survival analysis describing the association of body mass index on time to revision for total hip and knee replacements: results from the UK general practice research database.” BMJ Open. 3: e003614.

14) Dennison, E. M., Dhanwal, D. K., Shaheen, S. O., Azagra, R., Reading, I., Jameson, K. A., et al. (2013). “Is lung function associated with bone mineral density? Results from the Hertfordshire Cohort Study.” Arch.Osteoporos. 8: 115.

15) Dennison, E. M., Harvey, N. C. and Cooper, C. (2013). “Programming of osteoporosis and impact on osteoporosis risk.” Clin.Obstet.Gynecol. 56: 549-555.

16) Dhanwal, D. K., Siwach, R., Dixit, V., Mithal, A., Jameson, K. and Cooper, C. (2013). “Incidence of hip fracture in Rohtak district, North India.” Arch.Osteoporos. 8: 135.

17) Edwards, M. H., Gregson, C. L., Patel, H. P., Jameson, K. A., Harvey, N. C., Sayer, A. A., et al. (2013). “Muscle size, strength, and physical performance and their associations with bone structure in the Hertfordshire Cohort Study.” J.Bone Miner.Res. 28: 2295-2304.

18) Edwards, M. H., Jameson, K., Denison, H., Harvey, N. C., Sayer, A. A., Dennison, E. M., et al. (2013). “Clinical risk factors, bone density and fall history in the prediction of incident fracture among men and women.” Bone 52: 541-547.

19) Freemantle, N., Cooper, C., Diez-Perez, A., Gitlin, M., Radcliffe, H., Shepherd, S., et al. (2013). “Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.” Osteoporos.Int. 24: 209-217.

20) Freimann, T., Coggon, D., Merisalu, E., Animagi, L. and Paasuke, M. (2013). “Risk factors for musculoskeletal pain amongst nurses in Estonia: a cross-sectional study.” BMC Musculoskelet.Disord. 14: 334.

21) Gregson, C. L., Hardcastle, S. A., Cooper, C. and Tobias, J. H. (2013). “Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.” Rheumatology.(Oxford) 52: 968-985.

22) Gregson, C. L., Paggiosi, M. A., Crabtree, N., Steel, S. A., McCloskey, E., Duncan, E. L., et al. (2013). “Analysis of body composition in individuals with high bone mass reveals a marked increase in fat mass in women but not men.” J.Clin.Endocrinol.Metab 98: 818-828.

23) Gregson, C. L., Sayers, A., Lazar, V., Steel, S., Dennison, E. M., Cooper, C., et al. (2013). “The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: Findings from a pQCT case-control study.” Bone 52: 380-388.

24) Guillemin, F., Martinez, L., Calvert, M., Cooper, C., Ganiats, T., Gitlin, M., et al. (2013). “Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study.” Osteoporos.Int. 24: 3001-3010.

25) Harvey, N. C., Cole, Z. A., Crozier, S. R., Ntani, G., Mahon, P. A., Robinson, S. M., et al. (2013). “Fetal and infant growth predict hip geometry at 6 y old: findings from the Southampton Women’s Survey.” Pediatr.Res. 74: 450-456.

26) Harvey, N. C., Javaid, M. K., Inskip, H. M., Godfrey, K. M. and Cooper, C. (2013). “Maternal vitamin D status during pregnancy and bone-mineral content in offspring.” Lancet 382: 766.

27) Harvey, N. C., Matthews, P., Collins, R. and Cooper, C. (2013). “Osteoporosis epidemiology in UK Biobank: a unique opportunity for international researchers.” Osteoporos.Int. 24: 2903-2905.

28) Hernlund, E., Svedbom, A., Ivergard, M., Compston, J., Cooper, C., Stenmark, J., et al. (2013). “Osteoporosis in the European Union: medical management, epidemiology and economic burden : A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).” Arch.Osteoporos. 8: 136.

29) Hiligsmann, M., Cooper, C., Arden, N., Boers, M., Branco, J. C., Luisa, B. M., et al. (2013). “Health economics in the field of osteoarthritis: An Expert’s consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).” Semin.Arthritis Rheum. 43: 303-313.

30) Hiligsmann, M., Kanis, J. A., Compston, J., Cooper, C., Flamion, B., Bergmann, P., et al. (2013). “Health technology assessment in osteoporosis.” Calcif.Tissue Int. 93: 1-14.

31) Hudson, G., Panoutsopoulou, K., Wilson, I., Southam, L., Rayner, N. W., Arden, N., et al. (2013). “No evidence of an association between mitochondrial DNA variants and osteoarthritis in 7393 cases and 5122 controls.” Ann.Rheum.Dis. 72: 136-139.

32) Ioannidis, G., Flahive, J., Pickard, L., Papaioannou, A., Chapurlat, R. D., Saag, K. G., et al. (2013). “Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).” Osteoporos.Int. 24: 59-67.

33) Javaid, M. K. and Cooper, C. (2013). “Commentary: Opportunities to prevent fracture are being missed.” BMJ 346: f278.

34) Judge, A., Arden, N. K., Batra, R. N., Thomas, G., Beard, D., Javaid, M. K., et al. (2013). “The association of patient characteristics and surgical variables on symptoms of pain and function over 5 years following primary hip-replacement surgery: a prospective cohort study.” BMJ Open 3: pii: e002453.

35) Kanis, J. A., Adachi, J. D., Cooper, C., Clark, P., Cummings, S. R., Diaz-Curiel, M., et al. (2013). “Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF.” Osteoporos.Int. 24: 2763-2764.

36) Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R. and Reginster, J. Y. (2013). “European guidance for the diagnosis and management of osteoporosis in postmenopausal women.” Osteoporos.Int. 24: 23-57.

37) Kaufman, J. M., Reginster, J. Y., Boonen, S., Brandi, M. L., Cooper, C., Dere, W., et al. (2013). “Treatment of osteoporosis in men.” Bone 53: 134-144.

38) Kynaston-Pearson, F., Ashmore, A. M., Malak, T. T., Rombach, I., Taylor, A., Beard, D., et al. (2013). “Primary hip replacement prostheses and their evidence base: systematic review of literature.” BMJ 347: f6956.

39) Lalmohamed, A., MacGregor, A. J., de Vries, F., Leufkens, H. G. and van Staa, T. P. (2013). “Patterns of Risk of Cancer in Patients with Metal-on-Metal Hip Replacements versus Other Bearing Surface Types: A Record Linkage Study between a Prospective Joint Registry and General Practice Electronic Health Records in England.” PLoS.One. 8: e65891.

40) Litwic, A., Edwards, M. H., Dennison, E. M. and Cooper, C. (2013). “Epidemiology and burden of osteoarthritis.” Br.Med.Bull. 105: 185-199.

41) Lotz, M., Martel-Pelletier, J., Christiansen, C., Brandi, M. L., Bruyere, O., Chapurlat, R., et al. (2013). “Value of biomarkers in osteoarthritis: current status and perspectives.” Ann.Rheum.Dis. 72: 1756-1763.

42) Martin, K. R., Kuh, D., Harris, T. B., Guralnik, J. M., Coggon, D. and Wills, A. K. (2013). “Body mass index, occupational activity, and leisure-time physical activity: an exploration of risk factors and modifiers for knee osteoarthritis in the 1946 British birth cohort.” BMC Musculoskelet.Disord. 14: 219.

43) Moon, R. J. and Harvey, N. C. (2013). “Maternal pregnancy vitamin D status and offspring musculoskeletal health.” Expert Review of Obstetrics & Gynecology 8: 301-303.

44) Naidoo, S., Bowen, C., Arden, N. and Redmond, A. (2013). “Training the next generation of clinical researchers: evaluation of a graduate podiatrist research internship in rheumatology.” J.Foot Ankle Res. 6: 15.

45) Pelletier, J. P., Cooper, C., Peterfy, C., Reginster, J. Y., Brandi, M. L., Bruyere, O., et al. (2013). “What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?” Ann.Rheum.Dis. 72: 1594-1604.

46) Peters, M. J., Broer, L., Willemen, H. L., Eiriksdottir, G., Hocking, L. J., Holliday, K. L., et al. (2013). “Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region.” Ann.Rheum.Dis. 72: 427-436.

47) Pouwels, S., Bazelier, M. T., de Boer, A., Weber, W. E., Neef, C., Cooper, C., et al. (2013). “Risk of fracture in patients with Parkinson’s disease.” Osteoporos.Int. 24: 2283-2290.

48) Pouwels, S., Bazelier, M. T., de Boer, A., Weber, W. E., Neef, C. K., Cooper, C., et al. (2013). “Five-year fracture risk estimation in patients with Parkinson’s disease.” Bone 56: 266-270.

49) Pouwels, S., de Boer, A., Javaid, M. K., Hilton-Jones, D., Verschuuren, J., Cooper, C., et al. (2013). “Fracture rate in patients with myasthenia gravis: the general practice research database.” Osteoporos.Int. 24: 467-476.

50) Prieto-Alhambra, D., Nogues, X., Javaid, M. K., Wyman, A., Arden, N. K., Azagra, R., et al. (2013). “An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW).” Ann.Rheum.Dis. 72: 911-917.

51) Reginster, J. Y., Badurski, J., Bellamy, N., Bensen, W., Chapurlat, R., Chevalier, X., et al. (2013). “Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.” Ann.Rheum.Dis. 72: 179-186.

52) Rizzoli, R., Boonen, S., Brandi, M. L., Bruyere, O., Cooper, C., Kanis, J. A., et al. (2013). “Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).” Curr.Med.Res.Opin. 29: 305-313.

53) Soni, A., Batra, R. N., Gwilym, S. E., Spector, T. D., Hart, D. J., Arden, N. K., et al. (2013). “Neuropathic features of joint pain: a community-based study.” Arthritis Rheum. 65: 1942-1949.

54) Svedbom, A., Alvares, L., Cooper, C., Marsh, D. and Strom, O. (2013). “Balloon kyphoplasty compared to vertebroplasty and nonsurgical management in patients hospitalised with acute osteoporotic vertebral compression fracture: a UK cost-effectiveness analysis.” Osteoporos.Int. 24: 355-367.

55) Svedbom, A., Hernlund, E., Ivergard, M., Compston, J., Cooper, C., Stenmark, J., et al. (2013). “Osteoporosis in the European Union: a compendium of country-specific reports.” Arch.Osteoporos. 8: 137.

56) Tom, S. E., Adachi, J. D., Anderson, F. A., Jr., Boonen, S., Chapurlat, R. D., Compston, J. E., et al. (2013). “Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in women.” J.Am.Geriatr.Soc. 61: 327-334.

57) Vestergaard, P., Prieto-Alhambra, D., Javaid, M. K. and Cooper, C. (2013). “Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.” Osteoporos.Int. 24: 671-680.

58) Ward, K., Adams, J. E., Prentice, A., Aihie Sayer, A. and Cooper, C. (2013). A life course approach to healthy musculoskeletal ageing. A life course approach to healthy ageing. D. Kuh, C. Cooper, R. Hardy, M. Richards and Y. Ben-Shlomo. Oxford, Oxford University Press.

59) Williams, E. L., Edwards, C. J., Cooper, C. and Oreffo, R. O. (2013). “The osteoarthritic niche and modulation of skeletal stem cell function for regenerative medicine.” J.Tissue Eng Regen.Med. 7: 589-608.

60) Worsley, P., Warner, M., Mottram, S., Gadola, S., Veeger, H. E., Hermens, H., et al. (2013). “Motor control retraining exercises for shoulder impingement: effects on function, muscle activation, and biomechanics in young adults.” J.Shoulder.Elbow.Surg. 22: e11-e19.

61) Yaqub, M. K., Ioannou, C., Javaid, M. K., Cooper, C., Papageorghiou, A. T. and Noble, J. A. (2013). “Fusion of 3D ultrasound images of the fetal femur improves boundary definition and volume measurement.” Fetal Diagn.Ther. 34: 158-165.

2012

1) Avenell, A., MacLennan, G. S., Jenkinson, D. J., McPherson, G. C., McDonald, A. M., Pant, P. R., et al. (2012). “Long-Term Follow-Up for Mortality and Cancer in a Randomized Placebo-Controlled Trial of Vitamin D3 and/or Calcium (RECORD Trial).” J.Clin.Endocrinol.Metab 97: 614-622.

2) Bazelier, M. T., de Vries, F., Bentzen, J., Vestergaard, P., Leufkens, H. G., van Staa, T. P., et al. (2012). “Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers.” Mult.Scler. 18: 622-627.

3) Bazelier, M. T., Gallagher, A. M., van Staa, T. P., Cooper, C., Leufkens, H. G., Vestergaard, P., et al. (2012). “Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?” Pharmacoepidemiol.Drug Saf 21: 507-514.

4) Bazelier, M. T., van Staa, T. P., Uitdehaag, B. M., Cooper, C., Leufkens, H. G., Vestergaard, P., et al. (2012). “A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.” Neurology 79: 922-928.

5) Bazelier, M. T., van Staa, T. P., Uitdehaag, B. M., Cooper, C., Leufkens, H. G., Vestergaard, P., et al. (2012). “Risk of fractures in patients with multiple sclerosis: a population-based cohort study.” Neurology 78: 1967-1973.

6) Bazelier, M. T., Vestergaard, P., Gallagher, A. M., van Staa, T. P., Cooper, C., Leufkens, H. G., et al. (2012). “Risk of fracture with thiazolidinediones: disease or drugs?” Calcif.Tissue Int. 90: 450-457.

7) Carugno, M., Pesatori, A. C., Ferrario, M. M., Ferrari, A. L., Silva, F. J., Martins, A. C., et al. (2012). “Physical and psychosocial risk factors for musculoskeletal disorders in Brazilian and Italian nurses.” Cad.Saude Publica 28: 1632-1642.

8) Castano Betancourt, M. C., Cailotto, F., Kerkhof, H. J., Cornelis, F. M., Doherty, S. A., Hart, D. J., et al. (2012). “Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis.” Proc.Natl.Acad.Sci.U.S.A 109: 8218-8223.

9) Cawston, H., Maravic, M., Fardellone, P., Gauthier, A., Kanis, J. A., Compston, J., et al. (2012). “Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model.” Arch.Osteoporos. 7: 237-246.

10) Cole, Z. A., Harvey, N. C., Kim, M., Ntani, G., Robinson, S. M., Inskip, H. M., et al. (2012). “Increased fat mass is associated with increased bone size but reduced volumetric density in pre pubertal children.” Bone 50: 562-567.

11) Consortium, a., Collaborators, a. and including Arden, N. K. (2012). “Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study.” Lancet 380: 815-823.

12) Cooper, C. and Harvey, N. C. (2012). “Osteoporosis risk assessment (editorial).” BMJ 344: e4191.

13) Cooper, C., Reginster, J. Y., Chapurlat, R., Christiansen, C., Genant, H., Bellamy, N., et al. (2012). “Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.” Curr.Med.Res.Opin. 28: 231-239.

14) Cooper, C., Reginster, J. Y., Cortet, B., Diaz-Curiel, M., Lorenc, R. S., Kanis, J. A., et al. (2012). “Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).” Curr.Med.Res.Opin. 28: 475-491.

15) Culliford, D. J., Maskell, J., Kiran, A., Judge, A., Javaid, M. K., Cooper, C., et al. (2012). “The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database.” Osteoarthritis.Cartilage. 20: 519-524.

16) Dennison, E. M., Compston, J. E., Flahive, J., Siris, E. S., Gehlbach, S. H., Adachi, J. D., et al. (2012). “Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).” Bone 50: 1288-1293.

17) Diez-Perez, A., Adachi, J. D., Agnusdei, D., Bilezikian, J. P., Compston, J. E., Cummings, S. R., et al. (2012). “Treatment failure in osteoporosis.” Osteoporos.Int. 23: 2769-2774.

18) Edwards, M. H. and Cooper, C. (2012). “Bone: the growing cost of fractures in Ireland.” Nat.Rev.Endocrinol. 8: 512-513.

19) Eisman, J. A., Bogoch, E. R., Dell, R., Harrington, J. T., McKinney, R. E., Jr., McLellan, A., et al. (2012). “Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention.” J.Bone Miner.Res. 27: 2039-2046.

20) Estrada, K., Styrkarsdottir, U., Evangelou, E., Hsu, Y. H., Duncan, E. L., Ntzani, E. E., et al. (2012). “Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.” Nat.Genet. 44: 491-501.

21) Eyre, S., Bowes, J., Diogo, D., Lee, A., Barton, A., Martin, P., et al. (2012). “High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.” Nat.Genet. 44: 1336-1340.

22) Ferari, S., Bianchi, M. L., Eisman, J. A., Foldes, A. J., Adami, S., Wahl, D. A., et al. (2012). “Osteoporosis in young adults – pathophysiology, diagnosis and management.” Osteoporosis International 23(12): 2735-2748.

23) Fisher, B. A., Plant, D., Lundberg, K., Charles, P., Barton, A., Venables, P. J., et al. (2012). “Heterogeneity of Anticitrullinated Peptide Antibodies and Response to Anti-Tumor Necrosis Factor Agents in Rheumatoid Arthritis.” J.Rheumatol. 39: 929-932.

24) Gale, C. R., Dennison, E. M., Edwards, M., Sayer, A. A. and Cooper, C. (2012). “Symptoms of anxiety or depression and risk of fracture in older people: the Hertfordshire Cohort Study.” Arch.Osteoporos. 7: 59-65.

25) Gauthier, A., Kanis, J. A., Jiang, Y., Dreinhofer, K., Martin, M., Compston, J., et al. (2012). “Burden of postmenopausal osteoporosis in Germany: estimations from a disease model.” Arch.Osteoporos. 7: 209-218.

26) Gehlbach, S., Saag, K. G., Adachi, J. D., Hooven, F. H., Flahive, J., Boonen, S., et al. (2012). “Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women.” J.Bone Miner.Res. 27: 645-653.

27) Guggina, P., Flahive, J., Hooven, F. H., Watts, N. B., Siris, E. S., Silverman, S., et al. (2012). “Characteristics associated with anti-osteoporosis medication use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.” Bone 51: 975-980.

28) Harvey, N., Dhanwal, D., Robinson, S., Kim, M., Inskip, H., Godfrey, K., et al. (2012). “Does maternal long chain polyunsaturated fatty acid status in pregnancy influence the bone health of children? The Southampton Women’s Survey.” Osteoporos.Int. 23: 2359-2367.

29) Harvey, N. C., Cole, Z. A., Crozier, S. R., Kim, M., Ntani, G., Goodfellow, L., et al. (2012). “Physical activity, calcium intake and childhood bone mineral: a population-based cross-sectional study.” Osteoporos.Int. 23: 121-130.

30) Harvey, N. C. and Cooper, C. (2012). “Vitamin D: some perspective please (editorial).” BMJ 345: e4695.

31) Harvey, N. C., Javaid, K., Bishop, N., Kennedy, S., Papageorghiou, A. T., Fraser, R., et al. (2012). “MAVIDOS Maternal Vitamin D Osteoporosis Study: study protocol for a randomized controlled trial. The MAVIDOS Study Group.” Trials 13: 13.

32) Harvey, N. C., Lillycrop, K. A., Garratt, E., Sheppard, A., McLean, C., Burdge, G., et al. (2012). “Evaluation of methylation status of the eNOS promoter at birth in relation to childhood bone mineral content.” Calcif.Tissue Int. 90: 120-127.

33) Harvey, N. C., Mahon, P. A., Kim, M., Cole, Z. A., Robinson, S. M., Javaid, K., et al. (2012). “Intrauterine growth and postnatal skeletal development: findings from the Southampton Women’s Survey.” Paediatr.Perinat.Epidemiol. 26: 34-44.

34) Holroyd, C., Harvey, N., Dennison, E. and Cooper, C. (2012). “Epigenetic influences in the developmental origins of osteoporosis.” Osteoporos.Int. 23: 401-410.

35) Holroyd, C. R., Harvey, N. C., Crozier, S. R., Winder, N. R., Mahon, P. A., Ntani, G., et al. (2012). “Placental size at 19 weeks predicts offspring bone mass at birth: Findings from the Southampton Women’s Survey.” Placenta 33: 623-629.

36) Hooper, L., Bowen, C. J., Gates, L., Culliford, D. J., Ball, C., Edwards, C. J., et al. (2012). “Prognostic indicators of foot-related disability in patients with rheumatoid arthritis: Results of a prospective three-year study.” Arthritis Care Res.(Hoboken.) 64: 1116-1124.

37) Javaid, M. K., Kiran, A., Guermazi, A., Kwoh, C. K., Zaim, S., Carbone, L., et al. (2012). “Individual magnetic resonance imaging and radiographic features of knee osteoarthritis in subjects with unilateral knee pain: The health, aging, and body composition study.” Arthritis Rheum. 64: 3246-3255.

38) Judge, A., Arden, N. K., Cooper, C., Kassim, J. M., Carr, A. J., Field, R. E., et al. (2012). “Predictors of outcomes of total knee replacement surgery.” Rheumatology.(Oxford) 51: 1804-1813.

39) Judge, A., Javaid, M. K., Arden, N. K., Cushnaghan, J., Reading, I., Croft, P., et al. (2012). “Clinical tool to identify patients who are most likely to achieve long-term improvement in physical function after total hip arthroplasty.” Arthritis Care Res.(Hoboken.) 64: 881-889.

40) Kanis, J. A., Oden, A., McCloskey, E. V., Johansson, H., Wahl, D. A. and Cooper, C. (2012). “A systematic review of hip fracture incidence and probability of fracture worldwide.” Osteoporos.Int. 23: 2239-2256.

41) Kanis, J. A., Reginster, J. Y., Kaufman, J. M., Ringe, J. D., Adachi, J. D., Hiligsmann, M., et al. (2012). “A reappraisal of generic bisphosphonates in osteoporosis.” Osteoporos.Int. 23: 213-221.

42) Klop, C., de Vries, F., Lalmohamed, A., Mastbergen, S. C., Leufkens, H. G., WH, N.-v. d. L., et al. (2012). “COX-2-Selective NSAIDs and Risk of Hip or Knee Replacements: A Population-Based Case-Control Study.” Calcif.Tissue Int. 91: 387-394.

43) Kohler, J. A., Moon, R. J., Sands, R., Doherty, L. J., Taylor, P. A., Cooper, C., et al. (2012). “Selective reduction in trabecular volumetric bone mineral density during treatment for childhood acute lymphoblastic leukemia.” Bone 51: 765-770.

44) Lalmohamed, A., de Vries, F., Bazelier, M. T., Cooper, A., van Staa, T. P., Cooper, C., et al. (2012). “Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study.” BMJ 345: e5085.

45) Lalmohamed, A., Opdam, F., Arden, N. K., Prieto-Alhambra, D., van Staa, T., Leufkens, H. G., et al. (2012). “Knee arthroplasty and risk of hip fracture: a population-based, case-control study.” Calcif.Tissue Int. 90: 144-150.

46) Lalmohamed, A., Vestergaard, P., Cooper, C., de Boer, A., Leufkens, H. G., van Staa, T. P., et al. (2012). “Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort study.” Stroke 43: 3225-3229.

47) Lalmohamed, A., Welsing, P. M., Lems, W. F., Jacobs, J. W., Kanis, J. A., Johansson, H., et al. (2012). “Calibration of FRAX (R) 3.1 to the Dutch population with data on the epidemiology of hip fractures.” Osteoporos.Int. 23: 861-869.

48) Lekamwasam, S., Adachi, J. D., Agnusdei, D., Bilezikian, J., Boonen, S., Borgstrom, F., et al. (2012). “A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.” Osteoporos.Int. 23: 2257-2276.

49) Lekamwasam, S., Adachi, J. D., Agnusdei, D., Bilezikian, J., Boonen, S., Borgstrom, F., et al. (2012). “An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.” Arch.Osteoporos. 7: 25-30.

50) Lewis, R. M., Cleal, J. K., Ntani, G., Crozier, S. R., Mahon, P. A., Robinson, S. M., et al. (2012). “Relationship between placental expression of the imprinted PHLDA2 gene, intrauterine skeletal growth and childhood bone mass.” Bone 50: 337-342.

51) Leyland, K. M., Hart, D. J., Javaid, M. K., Judge, A., Kiran, A., Soni, A., et al. (2012). “The natural history of radiographic knee osteoarthritis: A fourteen-year population-based cohort study.” Arthritis Rheum. 64: 2243-2251.

52) Litwic, A., Edwards, M., Cooper, C. and Dennison, E. (2012). “Geographic differences in fractures among women.” Womens Health (Lond Engl.) 8: 673-684.

53) Nicholls, A. S., Kiran, A., Javaid, M. K., Hart, D. J., Spector, T. D., Carr, A. J., et al. (2012). “Change in body mass index during middle age affects risk of total knee arthoplasty due to osteoarthritis: a 19-year prospective study of 1003 women.” Knee. 19: 316-319.

54) Palmer, K. T. (2012). “The older worker with osteoarthritis of the knee.” Br.Med.Bull. 102: 79-88.

55) Palmer, K. T. (2012). “Occupational activities and osteoarthritis of the knee.” Br.Med.Bull. 102: 147-170.

56) Palmer, K. T., Griffin, M., Ntani, G., Shambrook, J., McNee, P., Sampson, M., et al. (2012). “Professional driving and prolapsed lumbar intervertebral disc diagnosed by magnetic resonance imaging: a case-control study.” Scand.J.Work Environ.Health 38: 577-581.

57) Palmer, K. T., Harris, E. C., Linaker, C., Barker, M., Lawrence, W., Cooper, C., et al. (2012). “Effectiveness of community- and workplace-based interventions to manage musculoskeletal-related sickness absence and job loss: a systematic review.” Rheumatology.(Oxford) 51: 230-242.

58) Patel, M. B., Makepeace, A. E., Jameson, K. A., Masterson, L. M., Holt, R. I., Swaminathan, R., et al. (2012). “Weight in infancy and adult calcium absorption as determinants of bone mineral density in adult men: the hertfordshire cohort study.” Calcif.Tissue Int. 91: 416-422.

59) Pfeilschifter, J., Cooper, C., Watts, N. B., Flahive, J., Saag, K. G., Adachi, J. D., et al. (2012). “Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women.” Osteoporos.Int. 23: 2179-2188.

60) Prieto-Alhambra, D., Aviles, F. F., Judge, A., van Staa, T., Nogues, X., Arden, N. K., et al. (2012). “Burden of pelvis fracture: a population-based study of incidence, hospitalisation and mortality.” Osteoporos.Int. 23: 2797-2803.

61) Prieto-Alhambra, D., Servitja, S., Javaid, M. K., Garrigos, L., Arden, N. K., Cooper, C., et al. (2012). “Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study.” Breast Cancer Res.Treat. 133: 1159-1167.

62) Rejnmark, L., Avenell, A., Masud, T., Anderson, F., Meyer, H. E., Sanders, K. M., et al. (2012). “Vitamin d with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin d trials.” J.Clin.Endocrinol.Metab 97: 2670-2681.

63) Rizzoli, R., Adachi, J. D., Cooper, C., Dere, W., Devogelaer, J. P., Diez-Perez, A., et al. (2012). “Management of glucocorticoid-induced osteoporosis.” Calcif.Tissue Int. 91: 225-243.

64) Rizzoli, R., Cooper, C., Reginster, J. Y., Abrahamsen, B., Adachi, J. D., Brandi, M. L., et al. (2012). “Antidepressant medications and osteoporosis.” Bone 51: 606-613.

65) Roux, C., Wyman, A., Hooven, F. H., Gehlbach, S. H., Adachi, J. D., Chapurlat, R. D., et al. (2012). “Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women : The Global Longitudinal study of Osteoporosis in Women (GLOW).” Osteoporos.Int. 23: 2863-2871.

66) Shepstone, L., Fordham, R., Lenaghan, E., Harvey, I., Cooper, C., Gittoes, N., et al. (2012). “A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study.” Osteoporos.Int. 23: 2507-2515.

67) Soni, A., Kiran, A., Hart, D. J., Leyland, K. M., Goulston, L., Cooper, C., et al. (2012). “Prevalence of reported knee pain over twelve years in a community-based cohort.” Arthritis Rheum. 64: 1145-1152.

68) Syddall, H. E., Evandrou, M., Dennison, E. M., Cooper, C. and Sayer, A. A. (2012). “Social inequalities in osteoporosis and fracture among community-dwelling older men and women: findings from the Hertfordshire cohort study.” Arch.Osteoporos. 7: 37-48.

69) Tandon, N., Fall, C. H., Osmond, C., Sachdev, H. P., Prabhakaran, D., Ramakrishnan, L., et al. (2012). “Growth from birth to adulthood and peak bone mass and density data from the New Delhi Birth Cohort.” Osteoporos.Int. 23: 2447-2459.

70) Valdes, A. M., Doherty, S., Muir, K. R., Zhang, W., Maciewicz, R. A., Wheeler, M., et al. (2012). “Genetic contribution to radiographic severity in osteoarthritis of the knee.” Ann.Rheum.Dis. 71: 1537-1540.

71) Wahl, D. A., Cooper, C., Ebeling, P. R., Eggersdorfer, M., Hilger, J., Hoffmann, K., et al. (2012). “A global representation of vitamin D status in healthy populations.” Arch.Osteoporos. 7: 155-172.

72) Williams, E. L., Edwards, C. J., Cooper, C. and Oreffo, R. O. (2012). “Impact of inflammation on the osteoarthritic niche: implications for regenerative medicine.” Regen.Med. 7: 551-570.

73) Wills, A. K., Black, S., Cooper, R., Coppack, R. J., Hardy, R., Martin, K. R., et al. (2012). “Life course body mass index and risk of knee osteoarthritis at the age of 53 years: evidence from the 1946 British birth cohort study.” Ann.Rheum.Dis. 71: 655-660.

74) Zheng, H. F., Tobias, J. H., Duncan, E., Evans, D. M., Eriksson, J., Paternoster, L., et al. (2012). “WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk.” PLoS.Genet. 8: e1002745.

2011

1) Arden, N. K., Kiran, A., Judge, A., Biant, L. C., Javaid, M. K., Murray, D. W., et al. (2011). “What is a good patient reported outcome after total hip replacement?” Osteoarthritis Cartilage 19: 155-162.

2) Baird, J., Kurshid, M. A., Kim, M., Harvey, N., Dennison, E. and Cooper, C. (2011). “Does birthweight predict bone mass in adulthood? A systematic review and meta-analysis.” Osteoporos.Int 22: 1323-1334.

3) Bazelier, M. T., van Staa, T., Uitdehaag, B. M., Cooper, C., Leufkens, H. G., Vestergaard, P., et al. (2011). “The risk of fracture in patients with multiple sclerosis: The UK general practice research database.” J.Bone Miner.Res. 26: 2271-2279.

4) Blank, R. D. and including Cooper, C. (2011). “Official Positions for FRAX(R) clinical regarding prior fractures from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R).” J.Clin.Densitom. 14: 205-211.

5) Blumsohn, A., Marin, F., Nickelsen, T., Brixen, K., Sigurdsson, G., Gonzalez, d. l., V, et al. (2011). “Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide.” Osteoporos.Int 22: 1935-1946.

6) Bolland, B. J., Culliford, D. J., Langton, D. J., Millington, J. P., Arden, N. K. and Latham, J. M. (2011). “High failure rates with a large-diameter hybrid metal-on-metal total hip replacement: CLINICAL, RADIOLOGICAL AND RETRIEVAL ANALYSIS.” J Bone Joint Surg.Br. 93: 608-615.

7) Bolland, B. J., Culliford, D. J., Maskell, J., Latham, J. M., Dunlop, D. G. and Arden, N. K. (2011). “The effect of hip and knee arthroplasty on oral anti-inflammatory use and the relationship to body mass index: results from the UK general practice research database.” Osteoarthritis Cartilage 19: 29-36.

8) Bowen, C. J., Culliford, D., Allen, R., Beacroft, J., Gay, A., Hooper, L., et al. (2011). “Forefoot pathology in rheumatoid arthritis identified with ultrasound may not localise to areas of highest pressure: cohort observations at baseline and twelve months.” J.Foot Ankle Res. 4: 25.

9) Broy, S. B., Tanner, S. B. and including Cooper, C. (2011). “Official Positions for FRAX(R) clinical regarding rheumatoid arthritis from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R).” J.Clin.Densitom. 14: 184-189.

10) Cauley, J. A., El-Hajj, F. G., Arabi, A., Fujiwara, S., Ragi-Eis, S., Calderon, A., et al. (2011). “Official Positions for FRAX(R) clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R).” J.Clin.Densitom. 14: 240-262.

11) Cauley, J. A., El-Hajj, F. G., Luckey, M. M. and including Cooper, C. (2011). “FRAX(R) International Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.” J.Clin.Densitom. 14: 237-239.

12) Compston, J. E., Watts, N. B., Chapurlat, R., Cooper, C., Boonen, S., Greenspan, S., et al. (2011). “Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW.” Am.J.Med. 124: 1043-1050.

13) Cooper, C. and Arden, N. K. (2011). “Excess mortality in osteoarthritis (editorial).” BMJ 342: d1407.

14) Cooper, C., Cole, Z. A., Holroyd, C. R., Earl, S. C., Harvey, N. C., Dennison, E. M., et al. (2011). “Secular trends in the incidence of hip and other osteoporotic fractures.” Osteoporos.Int 22: 1277-1288.

15) Cooper, C., Mitchell, P. and Kanis, J. A. (2011). “Breaking the fragility fracture cycle (editorial).” Osteoporos.Int 22: 2049-2050.

16) Day-Williams, A. G., Southam, L., Panoutsopoulou, K., Rayner, N. W., Esko, T., Estrada, K., et al. (2011). “A variant in MCF2L is associated with osteoarthritis.” Am.J.Hum.Genet. 89: 446-450.

17) Dennison, E. and Cooper, C. (2011). “Osteoporosis in 2010: building bones and (safely) preventing breaks.” Nat.Rev.Rheumatol 7: 80-82.

18) Dhanwal, D. K., Dennison, E. M., Harvey, N. C. and Cooper, C. (2011). “Epidemiology of hip fracture: Worldwide geographic variation.” Indian J Orthop. 45: 15-22.

19) Diez-Perez, A., Hooven, F. H., Adachi, J. D., Adami, S., Anderson, F. A., Boonen, S., et al. (2011). “Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).” Bone 49: 493-498.

20) Dimai, H. P., Chandran, M. and including Cooper, C. (2011). “Official Positions for FRAX(R) clinical regarding smoking from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R).” J.Clin.Densitom. 14: 190-193.

21) Duncan, E. L., Danoy, P., Kemp, J. P., Leo, P. J., McCloskey, E., Nicholson, G. C., et al. (2011). “Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk.” PLoS.Genet. 7: e1001372.

22) Evangelou, E., Valdes, A. M., Kerkhof, H. J., Styrkarsdottir, U., Zhu, Y., Meulenbelt, I., et al. (2011). “Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22.” Ann.Rheum.Dis. 70: 349-355.

23) Gauthier, A., Kanis, J. A., Martin, M., Compston, J., Borgstrom, F., Cooper, C., et al. (2011). “Development and validation of a disease model for postmenopausal osteoporosis.” Osteoporos.Int 22: 771-780.

24) Goulston, L. M., Kiran, A., Javaid, M. K., Soni, A., White, K. M., Hart, D. J., et al. (2011). “Does obesity predict knee pain over fourteen years in women, independently of radiographic changes?” Arthritis Care Res.(Hoboken.) 63: 1398-1406.

25) Hans, D. B., Kanis, J. A., Baim, S., Bilezikian, J. P., Binkley, N., Cauley, J. A., et al. (2011). “Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX((R)). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX(R) in clinical practice.” J.Clin.Densitom. 14: 171-180.

26) Harvey, N. C., Inskip, H. M., Godfrey, K. M. and Cooper, C. (2011). “Similar maternal and paternal relationships with offspring bone mass do not exclude an intrauterine mechanism: evidence from Southampton Women’s Survey.” Osteoporos.Int. 22: 2899-2900.

27) Holroyd, C. R., Cooper, C. and Harvey, N. C. (2011). “Vitamin D and the postmenopausal population.” Menopause.Int. 17: 102-107.

28) Holroyd, C. R. and Harvey, N. C. (2011). “Bone unfriendly drugs.” Osteoporosis Review 19(3): 1-6.

29) Hunter, D. J., Arden, N., Conaghan, P. G., Eckstein, F., Gold, G., Grainger, A., et al. (2011). “Definition of osteoarthritis on MRI: results of a Delphi exercise.” Osteoarthritis.Cartilage. 19: 963-969.

30) Javaid, M. K., Eriksson, J. G., Kajantie, E., Forsen, T., Osmond, C., Barker, D. J., et al. (2011). “Growth in childhood predicts hip fracture risk in later life.” Osteoporos.Int 22: 69-73.

31) Javaid, M. K., Prieto-Alhambra, D., Lui, L. Y., Cawthon, P., Arden, N. K., Lang, T., et al. (2011). “Self-reported weight at birth predicts measures of femoral size but not volumetric BMD in eldery men: MrOS.” J.Bone Miner.Res. 26: 1802-1807.

32) Jordan, J. M., Sowers, M. F., Messier, S. P., Bradley, J., Arangio, G., Katz, J. N., et al. (2011). “Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritis.” Osteoarthritis Cartilage 19: 500-508.

33) Judge, A., Cooper, C., Arden, N. K., Williams, S., Hobbs, N., Dixon, D., et al. (2011). “Pre-operative expectation predicts 12-month post-operative outcome among patients undergoing primary total hip replacement in European orthopaedic centres.” Osteoarthritis Cartilage 19: 659-667.

34) Kanis, J. A., Cooper, C., Hiligsmann, M., Rabenda, V., Reginster, J. Y. and Rizzoli, R. (2011). “Partial adherence: a new perspective on health economic assessment in osteoporosis.” Osteoporos.Int. 22: 2565-2573.

35) Kanis, J. A., Hans, D., Cooper, C., Baim, S., Bilezikian, J. P., Binkley, N., et al. (2011). “Interpretation and use of FRAX in clinical practice.” Osteoporos.Int. 22: 2395-2411.

36) Kerkhof, H. J., Doherty, M., Arden, N. K., Abramson, S. B., Attur, M., Bos, S. D., et al. (2011). “Large-scale meta-analysis of interleukin-1 beta and interleukin-1 receptor antagonist polymorphisms on risk of radiographic hip and knee osteoarthritis and severity of knee osteoarthritis.” Osteoarthritis Cartilage 19: 265-271.

37) Kerkhof, H. J., Meulenbelt, I., Akune, T., Arden, N. K., Aromaa, A., Bierma-Zeinstra, S. M., et al. (2011). “Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium.” Osteoarthritis Cartilage 19: 254-264.

38) Lanham, S. A., Bertram, C., Cooper, C. and Oreffo, R. O. (2011). “Animal models of maternal nutrition and altered offspring bone structure – Bone development across the lifecourse.” Eur.Cell Mater. 22: 321-332.

39) Lanham, S. A., Fowden, A. L., Roberts, C., Cooper, C., Oreffo, R. O. and Forhead, A. J. (2011). “Effects of hypothyroidism on the structure and mechanical properties of bone in the ovine fetus.” J.Endocrinol. 210: 189-198.

40) Lanham-New, S. A., Buttriss, J. L., Miles, L. M., Ashwell, M., Berry, J. L., Boucher, B. J., et al. (2011). “Proceedings of the Rank Forum on Vitamin D.” Br.J Nutr. 105: 144-156.

41) Leaver, R., Harris, E. C. and Palmer, K. T. (2011). “Musculoskeletal pain in elite professional musicians from British symphony orchestras.” Occup.Med.(Lond) 61: 549-555.

42) Leib, E. S., Saag, K. G., Adachi, J. D., Geusens, P. P., Binkley, N., McCloskey, E. V., et al. (2011). “Official Positions for FRAX((R)) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX((R)) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX((R)).” J.Clin.Densitom. 14: 212-219.

43) Lewiecki, E. M., Compston, J. E., Miller, P. D., Adachi, J. D., Adams, J. E., Leslie, W. D., et al. (2011). “FRAX((R)) Bone Mineral Density Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.” J.Clin.Densitom. 14: 223-225.

44) Lewiecki, E. M., Compston, J. E., Miller, P. D., Adachi, J. D., Adams, J. E., Leslie, W. D., et al. (2011). “Official Positions for FRAX(R) Bone Mineral Density and FRAX(R) simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R).” J.Clin.Densitom. 14: 226-236.

45) Linaker, C., Harris, E. C., Cooper, C., Coggon, D. and Palmer, K. T. (2011). “The burden of sickness absence from musculoskeletal causes in Great Britain.” Occup.Med.(Lond) 61: 458-464.

46) Marsh, D., Akesson, K., Beaton, D. E., Bogoch, E. R., Boonen, S., Brandi, M. L., et al. (2011). “Coordinator-based systems for secondary prevention in fragility fracture patients.” Osteoporos.Int. 22: 2051-2065.

47) Masud, T., Binkley, N., Boonen, S., Hannan, M. T. and including Cooper, C. (2011). “Official Positions for FRAX(R) clinical regarding falls and frailty: can falls and frailty be used in FRAX(R)? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R).” J.Clin.Densitom. 14: 194-204.

48) McCloskey, E. V., Binkley, N. and including Cooper, C. (2011). “FRAX((R)) Clinical Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.” J.Clin.Densitom. 14: 181-183.

49) McCloskey, E. V., Vasikaran, S. and Cooper, C. (2011). “Official Positions for FRAX(R) clinical regarding biochemical markers from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R).” J.Clin.Densitom. 14: 220-222.

50) Muraki, S., Dennison, E., Jameson, K., Boucher, B. J., Akune, T., Yoshimura, N., et al. (2011). “Association of vitamin D status with knee pain and radiographic knee osteoarthritis.” Osteoarthritis.Cartilage. 19: 1301-1306.

51) Nicholls, A. S., Kiran, A., Pollard, T. C., Hart, D. J., Arden, C. P., Spector, T., et al. (2011). “The association between hip morphology parameters and nineteen-year risk of end-stage osteoarthritis of the hip: a nested case-control study.” Arthritis Rheum. 63: 3392-3400.

52) Panoutsopoulou, K., Southam, L., Elliott, K. S., Wrayner, N., Zhai, G., Beazley, C., et al. (2011). “Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study.” Ann.Rheum.Dis. 70: 864-867.

53) Pazianas, M., Cooper, C., Wang, Y., Lange, J. L. and Russell, R. G. (2011). “Atrial fibrillation and the use of oral bisphosphonates.” Ther.Clin Risk Manag. 7: 131-144.

54) Pouwels, S., Lalmohamed, A., Souverein, P., Cooper, C., Veldt, B. J., Leufkens, H. G., et al. (2011). “Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.” Osteoporos.Int 22: 903-910.

55) Prieto-Alhambra, D., Javaid, M. K., Judge, A., Maskell, J., Kiran, A., Cooper, C., et al. (2011). “Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.” Osteoporos.Int 22: 1555-1571.

56) Prieto-Alhambra, D., Javaid, M. K., Judge, A., Maskell, J., Kiran, A., de Vries, F., et al. (2011). “Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.” Arthritis Rheum. 63: 992-1001.

57) Prieto-Alhambra, D., Javaid, M. K., Judge, A., Murray, D., Carr, A., Cooper, C., et al. (2011). “Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.” BMJ 343: d7222.

58) Prieto-Alhambra, D., Javaid, M. K., Maskell, J., Judge, A., Nevitt, M., Cooper, C., et al. (2011). “Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study.” Ann.Rheum.Dis. 70: 134-138.

59) Rizzoli, R., Akesson, K., Bouxsein, M., Kanis, J. A., Napoli, N., Papapoulos, S., et al. (2011). “Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.” Osteoporos.Int 22: 373-390.

60) Rizzoli, R., Reginster, J. Y., Boonen, S., Breart, G., Diez-Perez, A., Felsenberg, D., et al. (2011). “Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.” Calcif.Tissue Int. 89: 91-104.

61) Roux, C., Cooper, C., ez-Perez, A., Martinez, L., Ortolani, S., Gitlin, M., et al. (2011). “Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU((R)) study.” Osteoporos.Int 22: 1227-1236.

62) Sambrook, P. N., Flahive, J., Hooven, F. H., Boonen, S., Chapurlat, R., Lindsay, R., et al. (2011). “Predicting fractures in an international cohort using risk factor algorithms without BMD.” J.Bone Miner.Res. 26: 2770-2777.

63) Schaap, L. A., Peeters, G. M., Dennison, E. M., Zambon, S., Nikolaus, T., Sanchez-Martinez, M., et al. (2011). “European Project on OSteoArthritis (EPOSA): methodological challenges in harmonization of existing data from five European population-based cohorts on aging.” BMC.Musculoskelet.Disord. 12: 272.

64) Shambrook, J., McNee, P., Harris, E. C., Kim, M., Sampson, M., Palmer, K. T., et al. (2011). “Clinical presentation of low back pain and association with risk factors according to findings on magnetic resonance imaging.” Pain 152: 1659-1665.

65) Siris, E. S., Gehlbach, S., Adachi, J. D., Boonen, S., Chapurlat, R. D., Compston, J. E., et al. (2011). “Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW).” Osteoporos.Int 22: 27-35.

66) Valdes, A. M., Arden, N. K., Vaughn, F. L., Doherty, S. A., Leaverton, P. E., Zhang, W., et al. (2011). “Role of the Nav1.7 R1150W amino acid change in susceptibility to symptomatic knee osteoarthritis and multiple regional pain.” Arthritis Care Res.(Hoboken.) 63: 440-444.

67) Valdes, A. M., De Wilde, G., Doherty, S. A., Lories, R. J., Vaughn, F. L., Laslett, L. L., et al. (2011). “The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis.” Ann.Rheum.Dis. 70: 1556-1561.

68) Valdes, A. M., Evangelou, E., Kerkhof, H. J., Tamm, A., Doherty, S. A., Kisand, K., et al. (2011). “The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance (letter).” Ann.Rheum.Dis. 70: 873-875.

69) Valdes, A. M., Styrkarsdottir, U., Doherty, M., Morris, D. L., Mangino, M., Tamm, A., et al. (2011). “Large Scale Replication Study of the Association between HLA Class II/BTNL2 Variants and Osteoarthritis of the Knee in European-Descent Populations.” PLoS.One. 6: e23371.

70) Varanasi, S. S., Tuck, S. P., Mastana, S. S., Dennison, E., Cooper, C., Vila, J., et al. (2011). “Lack of association of bone morphogenetic protein 2 gene haplotypes with bone mineral density, bone loss, or risk of fractures in men.” J.Osteoporos. 2011: 243465.

71) Vasikaran, S., Cooper, C., Eastell, R., Griesmacher, A., Morris, H. A., Trenti, T., et al. (2011). “International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis.” Clin.Chem.Lab Med. 49: 1271-1274.

72) Vasikaran, S., Eastell, R., Bruyere, O., Foldes, A. J., Garnero, P., Griesmacher, A., et al. (2011). “Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.” Osteoporos.Int 22: 391-420.

73) Vasikaran, S. D., Cooper, C. and Kanis, J. A. (2011). “Recommendations for bone marker standards in osteoporosis: what, why and where to now? (editorial).” Ann.Clin Biochem. 48: 91-92.

74) Westlake, S. L., Colebatch, A. N., Baird, J., Curzen, N., Kiely, P., Quinn, M., et al. (2011). “Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.” Rheumatology (Oxford) 50: 518-531.

75) Williams, F. M., Popham, M., Hart, D. J., de Schepper, E., Bierma-Zeinstra, S., Hofman, A., et al. (2011). “GDF5 single-nucleotide polymorphism rs143383 is associated with lumbar disc degeneration in Northern European women.” Arthritis Rheum. 63: 708-712.

2010

1) Abrahamsen, B., Masud, T., Avenell, A., Anderson, F., Meyer, H. E., Cooper, C., et al. (2010). “Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europexen,K.;.” BMJ 340: b5463.

2) Adachi, J. D., Adami, S., Gehlbach, S., Anderson, F. A., Jr., Boonen, S., Chapurlat, R. D., et al. (2010). “Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women.” Mayo Clin Proc. 85: 806-813.

3) Adams, J., Mullee, M., Burridge, J., Hammond, A. and Cooper, C. (2010). “Responsiveness of self-report and therapist-rated upper extremity structural impairment and functional outcome measures in early rheumatoid arthritis.” Arthritis Care Res.(Hoboken.) 62: 274-278.

4) Ayis, S., Arden, N., Doherty, M., Pollard, B., Johnston, M. and Dieppe, P. (2010). “Applying the impairment, activity limitation, and participation restriction constructs of the ICF model to osteoarthritis and low back pain trials: a reanalysis.” J Rheumatol 37: 1923-1931.

5) Bowen, C. J., Edwards, C. J., Hooper, L., Dewbury, K., Sampson, M., Sawyer, S., et al. (2010). “Improvement in symptoms and signs in the forefoot of patients with rheumatoid arthritis treated with anti-TNF therapy.” J Foot Ankle Res. 3: 10.

6) Bowen, C. J., Hooper, L., Culliford, D., Dewbury, K., Sampson, M., Burridge, J., et al. (2010). “Assessment of the natural history of forefoot bursae using ultrasonography in patients with rheumatoid arthritis: a twelve-month investigation.” Arthritis Care Res.(Hoboken.) 62: 1756-1762.

7) Breart, G., Cooper, C., Meyer, O., Speirs, C., Deltour, N. and Reginster, J. Y. (2010). “Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database.” Osteoporos.Int 21: 1181-1187.

8) Cooper, C. (2010). “Osteoporosis: disease severity and consequent fracture management.” Osteoporos.Int 21 Suppl 2: S425-S429.

9) Cooper, C. (2010). “Osteoporosis research thrives: IOF WCO-ECCEO10.” Expert.Rev.Pharmacoecon.Outcomes.Res. 10: 367-370.

10) Cooper, C., Steinbuch, M., Stevenson, R., Miday, R. and Watts, N. B. (2010). “The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK.” Osteoporos.Int 21: 569-577.

11) Culliford, D. J., Maskell, J., Beard, D. J., Murray, D. W., Price, A. J. and Arden, N. K. (2010). “Temporal trends in hip and knee replacement in the United Kingdom: 1991 to 2006.” J Bone Joint Surg.Br. 92: 130-135.

12) Dennison, E. M., Cooper, C. and Cole, Z. A. (2010). “Early development and osteoporosis and bone health.” Journal of Developmental Origins of Health and Disease 1: 142-149.

13) Dennison, E. M., Jameson, K. A., Syddall, H. E., Martin, H. J., Cushnaghan, J., Aihie, S. A., et al. (2010). “Bone health and deterioration in quality of life among participants from the Hertfordshire cohort study.” Osteoporos.Int 21: 1817-1824.

14) Dhanwal, D. K., Cooper, C. and Dennison, E. M. (2010). “Geographic variation in osteoporotic hip fracture incidence: the growing importance of asian influences in coming decades.” J Osteoporos. 2010: 757102.

15) Dhanwal, D. K., Kochupillai, N., Gupta, N., Cooper, C. and Dennison, E. M. (2010). “Hypovitaminosis D and bone mineral metabolism and bone density in hyperthyroidism.” J Clin Densitom. 13: 462-466.

16) Earl, S., Cole, Z. A., Holroyd, C., Cooper, C. and Harvey, N. C. (2010). “Session 2: Other diseases: Dietary management of osteoporosis throughout the life course.” Proc.Nutr.Soc. 69: 25-33.

17) Freemantle, N., Cooper, C., Roux, C., Diez-Perez, A., Guillemin, F., Jonsson, B., et al. (2010). “Baseline observations from the POSSIBLE EU(R) study: characteristics of postmenopausal women receiving bone loss medications.” Arch.Osteoporos. 5: 61-72.

18) Goodfellow, L. R., Earl, S., Cooper, C. and Harvey, N. C. (2010). “Maternal diet, behaviour and offspring skeletal health.” International Journal of Environmental Research and Public Health 7(4): 1760-1772.

19) Harvey, N., Dennison, E. and Cooper, C. (2010). “Osteoporosis: impact on health and economics.” Nat.Rev.Rheumatol 6: 99-105.

20) Harvey, N. C., Javaid, M. K., Arden, N. K., Poole, J. R., Crozier, S. R., Robinson, S. M., et al. (2010). “Maternal predictors of neonatal bone size and geometry: the Southampton Women’s Survey.” Journal of Developmental Origins of Health and Disease 1: 35-41.

21) Harvey, N. C., Mahon, P. A., Robinson, S. M., Nisbet, C. E., Javaid, M. K., Crozier, S. R., et al. (2010). “Different indices of fetal growth predict bone size and volumetric density at 4 years of age.” J Bone Miner.Res. 25: 920-927.

22) Hassan, B., Maxwell, J. R., Hyrich, K. L., Barton, A., Worthington, J., Isaacs, J. D., et al. (2010). “Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis.” Rheumatology (Oxford) 49: 43-47.

23) Holroyd, C. R., Davies, J. H., Taylor, P., Jameson, K., Rivett, C., Cooper, C., et al. (2010). “Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome.” Osteoporos.Int 21: 2093-2099.

24) Judge, A., Cooper, C., Williams, S., Dreinhoefer, K. and Dieppe, P. (2010). “Patient-reported outcomes one year after primary hip replacement in a European Collaborative Cohort.” Arthritis Care Res.(Hoboken.) 62: 480-488.

25) Langston, A. L., Campbell, M. K., Fraser, W. D., MacLennan, G. S., Selby, P. L., Ralston, S. H., et al. (2010). “Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget’s disease of bone.” J Bone Miner.Res. 25: 20-31.

26) Lewiecki, E. M., Cooper, C., Thompson, E., Hartl, F., Mehta, D. and Papapoulos, S. E. (2010). “Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials.” Int J Clin Pract. 64: 821-826.

27) Lips, P., Jameson, K., Bianchi, M. L., Goemaere, S., Boonen, S., Reeve, J., et al. (2010). “Validation of the IOF quality of life questionnaire for patients with wrist fracture.” Osteoporos.Int 21: 61-70.

28) Lyritis, G., Marin, F., Barker, C., Pfeifer, M., Farrerons, J., Brixen, K., et al. (2010). “Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS.” Curr.Med.Res.Opin. 26: 1799-1807.

29) Mahon, P., Harvey, N., Crozier, S., Inskip, H., Robinson, S., Arden, N., et al. (2010). “Low maternal vitamin D status and fetal bone development: cohort study.” J Bone Miner.Res. 25: 14-19.

30) Pazianas, M., Cooper, C., Ebetino, F. H. and Russell, R. G. (2010). “Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.” Ther.Clin Risk Manag. 6: 325-343.

31) Pouwels, S., Lalmohamed, A., van Staa, T., Cooper, C., Souverein, P., Leufkens, H. G., et al. (2010). “Use of organic nitrates and the risk of hip fracture: a population-based case-control study.” J Clin Endocrinol.Metab 95: 1924-1931.

32) Price, A. J., Longino, D., Rees, J., Rout, R., Pandit, H., Javaid, K., et al. (2010). “Are pain and function better measures of outcome than revision rates after TKR in the younger patient?” Knee. 17: 196-199.

33) Solidaki, E., Chatzi, L., Bitsios, P., Markatzi, I., Plana, E., Castro, F., et al. (2010). “Work-related and psychological determinants of multisite musculoskeletal pain.” Scand.J Work Environ.Health 36: 54-61.

34) Strom, O., Leonard, C., Marsh, D. and Cooper, C. (2010). “Cost-effectiveness of balloon kyphoplasty in patients with symptomatic vertebral compression fractures in a UK setting.” Osteoporos.Int 21: 1599-1608.

35) Valdes, A. M., Arden, N. K., Tamm, A., Kisand, K., Doherty, S., Pola, E., et al. (2010). “A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis.” Osteoarthritis.Cartilage. 18: 699-704.

36) Valdes, A. M., McWilliams, D., Arden, N. K., Doherty, S. A., Wheeler, M., Muir, K. R., et al. (2010). “Involvement of different risk factors in clinically severe large joint osteoarthritis according to the presence of hand interphalangeal nodes.” Arthritis Rheum. 62: 2688-2695.

37) Valdes, A. M., Spector, T. D., Tamm, A., Kisand, K., Doherty, S. A., Dennison, E. M., et al. (2010). “Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis.” Arthritis Rheum. 62: 2347-2352.

38) Wang, T. J., Zhang, F., Richards, J. B., Kestenbaum, B., van Meurs, J. B., Berry, D., et al. (2010). “Common genetic determinants of vitamin D insufficiency: a genome-wide association study.” Lancet 376: 180-188.

39) Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., et al. (2010). “The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.” Rheumatology (Oxford) 49: 295-307.

40) Zhang, W., Doherty, M., Peat, G., Bierma-Zeinstra, M. A., Arden, N. K., Bresnihan, B., et al. (2010). “EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis.” Ann.Rheum.Dis. 69: 483-489.

41) Zhang, W., Nuki, G., Moskowitz, R. W., Abramson, S., Altman, R. D., Arden, N. K., et al. (2010). “OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.” Osteoarthritis.Cartilage. 18: 476-499.

2009

1) Abdin-Mohamed, M., Jameson, K., Dennison, E. M., Cooper, C. and Arden, N. K. (2009). “Volumetric bone mineral density of the tibia is not increased in subjects with radiographic knee osteoarthritis.” Osteoarthritis.Cartilage. 17(2): 174-177.

2) Abrahamsen, B., van Staa, T., Ariely, R., Olson, M. and Cooper, C. (2009). “Excess mortality following hip fracture: a systematic epidemiological review.” Osteoporos.Int. 20: 1633-1650.

3) Boonen, S., Kay, R., Cooper, C., Haentjens, P., Vanderschueren, D., Callewaert, F., et al. (2009). “Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases.” Int J Clin Pract. 63: 1792-1804.

4) Cole, Z. A., Dennison, E. M. and Cooper, C. (2009). “The impact of methods for estimating bone health and the global burden of bone disease.” Salud Publica Mex. 51 Suppl 1: S38-S45.

5) Cole, Z. A., Gale, C. R., Javaid, M. K., Robinson, S. M., Law, C., Boucher, B. J., et al. (2009). “Maternal dietary patterns during pregnancy and childhood bone mass: a longitudinal study.” J.Bone Miner.Res. 24: 663-668.

6) Colebatch, A. N., Hart, D. J., Zhai, G., Williams, F. M., Spector, T. D. and Arden, N. K. (2009). “Effective measurement of knee alignment using AP knee radiographs.” Knee. 16: 42-45.

7) Compston, J., Cooper, A., Cooper, C., Francis, R., Kanis, J. A., Marsh, D., et al. (2009). “Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK.” Maturitas 62: 105-108.

8) Cooper, C., Harvey, N., Cole, Z., Hanson, M. and Dennison, E. (2009). “Developmental origins of osteoporosis: the role of maternal nutrition.” Adv.Exp.Med.Biol. 646: 31-39.

9) Cooper, C., Rizzoli, R. and Reginster, J. Y. (2009). “The International Osteoporosis Foundation: history, objectives and achievements.” Osteoporos.Int. 20 Suppl 3: S241-S242.

10) Cooper, C., Westlake, S., Harvey, N. and Dennison, E. (2009). “Developmental origins of osteoporotic fracture.” Adv.Exp.Med.Biol. 639: 217-236.

11) Cranney, A., Wells, G. A., Yetisir, E., Adami, S., Cooper, C., Delmas, P. D., et al. (2009). “Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.” Osteoporos.Int 20(2): 291-297.

12) de Vries, F., Cooper, A. L., Cockle, S. M., van Staa, T. P. and Cooper, C. (2009). “Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates.” Osteoporos.Int 20: 1989-1998.

13) Earl, S. and Harvey, N. (2009). “Osteoporosis Conference 2009 meeting report.” Osteoporosis Review 17: 9-12.

14) Harvey, N. C., Robinson, S. M., Crozier, S. R., Marriott, L. D., Gale, C. R., Cole, Z. A., et al. (2009). “Breast-feeding and adherence to infant feeding guidelines do not influence bone mass at age 4 years.” Br.J.Nutr. 102: 915-920.

15) Hooven, F. H., Adachi, J. D., Adami, S., Boonen, S., Compston, J., Cooper, C., et al. (2009). “The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.” Osteoporos.Int. 20: 1107-1116.

16) Lam, S. C., Allen, R., Pearson, G. and Cooper, C. (2009). “Parametric characterization of spinal motions in osteoporotic vertebral fracture at level T12 with fluoroscopy.” Med.Eng Phys. 31: 346-355.

17) Liu, B., Balkwill, A., Cooper, C., Roddam, A., Brown, A. and Beral, V. (2009). “Reproductive history, hormonal factors and the incidence of hip and knee replacement for osteoarthritis in middle-aged women.” Ann.Rheum.Dis. 68: 1165-1170.

18) Mahon, P. A., Cooper, C., Crozier, S. R. and Godfrey, K. M. (2009). “The use of 3D ultrasound to investigate fetal bone development.” Norwegian Journal of Epidemiology 19: 45-52.

19) Palmer, K. T., Cullinan, P., Rice, S., Brown, T. and Coggon, D. (2009). “Mortality from infectious pneumonia in metal workers: a comparison with deaths from asthma in occupations exposed to respiratory sensitisers.” Thorax 64: 983-986.

20) Pouwels, S., Lalmohamed, A., Leufkens, B., de Boer, A., Cooper, C., van Staa, T., et al. (2009). “Risk of hip/femur fracture after stroke: a population-based case-control study.” Stroke 40: 3281-3285.

21) Reid, D. M., Devogelaer, J. P., Saag, K., Roux, C., Lau, C. S., Reginster, J. Y., et al. (2009). “Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.” Lancet 373: 1253-1263.

22) van den Brand, M. W., Samson, M. M., Pouwels, S., van Staa, T. P., Thio, B., Cooper, C., et al. (2009). “Use of anti-depressants and the risk of fracture of the hip or femur.” Osteoporos.Int. 20: 1705-1713.

23) Williams, E. L., Harvey, N., Dennison, E., Edwards, C. and Cooper, C. (2009). “Maternal nutrition and bone health in the offspring.” Int J Clin Rheumatol 4: 133-145.

24) Winsloe, C., Earl, S., Dennison, E. M., Cooper, C. and Harvey, N. C. (2009). “Early life factors in the pathogenesis of osteoporosis.” Curr.Osteoporos.Rep. 7: 140-144.

2008

1) Adams, J., Burridge, J., Mullee, M., Hammond, A. and Cooper, C. (2008). “The clinical effectiveness of static resting splints in early rheumatoid arthritis: a randomized controlled trial.” Rheumatology.(Oxford) 47: 1548-1553.

2) Arden, N. K., Reading, I. C., Jordan, K. M., Thomas, L., Platten, H., Hassan, A., et al. (2008). “A randomised controlled trial of tidal irrigation vs corticosteroid injection in knee osteoarthritis: the KIVIS Study.” Osteoarthritis.Cartilage. 16: 733-739.

3) Ashwell, M., Stone, E., Mathers, J., Barnes, S., Compston, J., Francis, R. M., et al. (2008). “Nutrition and bone health projects funded by the UK Food Standards Agency: have they helped to inform public health policy?” Br.J Nutr. 99(1): 198-205.

4) Boonen, S., Marin, F., Obermayer-Pietsch, B., Simoes, M. E., Barker, C., Glass, E. V., et al. (2008). “Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis.” J Clin.Endocrinol Metab 93: 852-860.

5) Bruyere, O., Brandi, M. L., Burlet, N., Harvey, N., Lyritis, G., Minne, H., et al. (2008). “Post-fracture management of patients with hip fracture: a perspective.” Curr.Med.Res.Opin. 24: 2841-2851.

6) Bruyere, O., Burlet, N., Delmas, P. D., Rizzoli, R., Cooper, C. and Reginster, J. Y. (2008). “Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.” BMC.Musculoskelet.Disord. 9: 165.

7) Cole, Z., Dennison, E. and Cooper, C. (2008). “Update on the treatment of post-menopausal osteoporosis.” Br.Med Bull. 86: 129-143.

8) Cole, Z. A., Dennison, E. M. and Cooper, C. (2008). “Osteoporosis epidemiology update.” Curr.Rheumatol.Rep. 10: 92-96.

9) Cooper, C., Harvey, N., Javaid, K., Hanson, M. and Dennison, E. (2008). “Growth and bone development.” Nestle.Nutr.Workshop Ser.Pediatr.Program. 61: 53-68.

10) Cooper, C., Jakob, F., Chinn, C., Martin-Mola, E., Fardellone, P., Adami, S., et al. (2008). “Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).” Osteoporos.Int 19: 493-501.

11) Cox, H., Puffer, S., Morton, V., Cooper, C., Hodson, J., Masud, T., et al. (2008). “Educating nursing home staff on fracture prevention: a cluster randomised trial.” Age Ageing 37: 167-172.

12) Earl, S., Cooper, C. and Arden, N. (2008). “Osteoarthritis: ‘programming’ by the early environment.” Rheumatology in Practice 6: 4-7.

13) Harvey, N., Dennison, E. and Cooper, C. (2008). Epidemiology of osteoporotic fractures. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. C. Rosen. Washington, American Society for Bone and Mineral Research: 198-203.

14) Harvey, N. C., Dennison, E. M. and Cooper, C. (2008). “The importance of vitamin D in pregnancy and childhood (editorial).” National Knowledge Week on Osteoporosis.

15) Harvey, N. C., Javaid, M. K., Poole, J. R., Taylor, P., Robinson, S. M., Inskip, H. M., et al. (2008). “Paternal skeletal size predicts intrauterine bone mineral accrual.” J Clin.Endocrinol Metab 93: 1676-1681.

16) Hewlett, S., Cockshott, Z., Almeida, C., Richards, P., Lowe, R., Greenwood, R., et al. (2008). “Sensitivity to change of the Rheumatoid Arthritis Self-Efficacy scale (RASE) and predictors of change in self-efficacy.” Musculoskeletal.Care 6: 49-67.

17) Holroyd, C., Cooper, C. and Dennison, E. (2008). “Epidemiology of osteoporosis.” Best.Pract.Res.Clin.Endocrinol Metab 22: 671-685.

18) Kanis, J. A., Adams, J., Borgstrom, F., Cooper, C., Jonsson, B., Preedy, D., et al. (2008). “The cost-effectiveness of alendronate in the management of osteoporosis.” Bone 42(1): 4-15.

19) Kanis, J. A., Adams, J., Borgstrom, F., Cooper, C., Jonsson, B., Preedy, D., et al. (2008). “Modelling cost-effectiveness in osteoporosis.” Bone 43: 215-216.

20) Kanis, J. A., Burlet, N., Cooper, C., Delmas, P. D., Reginster, J. Y., Borgstrom, F., et al. (2008). “European guidance for the diagnosis and management of osteoporosis in postmenopausal women.” Osteoporos.Int. 19(4): 399-428.

21) Kanis, J. A., Compston, J. E. and including Cooper, C. (2008). “NICE continues to muddy the waters of osteoporosis.” Osteoporos.Int 19: 1105-1107.

22) Kanis, J. A., McCloskey, E. V., Johansson, H., Strom, O., Borgstrom, F., Oden, A., et al. (2008). “Case finding for the management of osteoporosis with FRAX–assessment and intervention thresholds for the UK.” Osteoporos.Int 19: 1395-1408.

23) Langdahl, B. L., Uitterlinden, A. G., Ralston, S. H., Trikalinos, T. A., Balcells, S., Brandi, M. L., et al. (2008). “Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.” Bone 42: 969-981.

24) Lanham, S. A., Roberts, C., Cooper, C. and Oreffo, R. O. (2008). “Intrauterine programming of bone. Part 1: Alteration of the osteogenic environment.” Osteoporos.Int. 19(2): 147-156.

25) Lanham, S. A., Roberts, C., Perry, M. J., Cooper, C. and Oreffo, R. O. (2008). “Intrauterine programming of bone. Part 2: Alteration of skeletal structure.” Osteoporos.Int. 19(2): 157-167.

26) Madan, I., Reading, I., Palmer, K. T. and Coggon, D. (2008). “Cultural differences in musculoskeletal symptoms and disability.” Int J Epidemiol 37: 1181-1189.

27) Moinuddin, M. M., Jameson, K. A., Syddall, H. E., Sayer, A. A., Martin, H. J., Robinson, S., et al. (2008). “Cigarette smoking, birthweight and osteoporosis in adulthood: results from the hertfordshire cohort study.” Open.Rheumatol.J 2: 33-37.

28) Obermayer-Pietsch, B. M., Marin, F., McCloskey, E. V., Hadji, P., Farrerons, J., Boonen, S., et al. (2008). “Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.” J Bone Miner.Res. 23: 1591-1600.

29) Thomas, S. L., Edwards, C. J., Smeeth, L., Cooper, C. and Hall, A. J. (2008). “How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database?” Arthritis Rheum. 59: 1314-1321.

30) van Meurs, J. B., Trikalinos, T. A., Ralston, S. H., Balcells, S., Brandi, M. L., Brixen, K., et al. (2008). “Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.” JAMA 299: 1277-1290.

31) van Staa, T. P., Cooper, C., Barlow, D. and Leufkens, H. G. (2008). “Individualizing the risks and benefits of postmenopausal hormone therapy.” Menopause. 15: 374-381.

2007

1) Cole, Z. A. and Cooper, C. (2007). “Bone modeling: the first step in the bone-building process.” Medicographia 29: 113-119.

2) Cushnaghan, J., Coggon, D., Reading, I., Croft, P., Byng, P., Cox, K., et al. (2007). “Long-term outcome following total hip arthroplasty: A controlled longitudinal study.” Arthritis Rheum. 57(8): 1375-1380.

3) de Vries, F., Pouwels, S., Lammers, J. W., Leufkens, H. G., Bracke, M., Cooper, C., et al. (2007). “Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.” J Intern.Med 261: 170-177.

4) de Vries, F., Souverein, P. C., Cooper, C., Leufkens, H. G. and van Staa, T. P. (2007). “Use of beta-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands.” Calcif.Tissue Int 80: 69-75.

5) Dennison, E. M., Syddall, H. E., Aihie Sayer, A., Martin, H. J. and Cooper, C. (2007). “Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study.” QJM. 100: 297-303.

6) Edwards, C. J., Cooper, C., Fisher, D., Field, M., van Staa, T. P. and Arden, N. K. (2007). “The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis.” Arthritis Rheum. 57(7): 1151-1157.

7) Edwards, C. J., Syddall, H., Goswami, R., Goswami, P., Dennison, E. M., Arden, N. K., et al. (2007). “The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men.” Heart 93(10): 1263-1267.

8) F., d. V., Bracke, M., Leufkens, H. G., Lammers, J. W., Cooper, C. and van Staa, T. P. (2007). “Fracture risk with intermittent high-dose oral glucocorticoid therapy.” Arthritis Rheum. 56(1): 208-214.

9) F., d. V., Pouwels, S., Bracke, M., Leufkens, H. G., Cooper, C., Lammers, J. W., et al. (2007). “Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.” Pharmacoepidemiol.Drug Saf 16(6): 612-619.

10) Harvey, N. C., Poole, J. R., Javaid, M. K., Dennison, E. M., Robinson, S., Inskip, H. M., et al. (2007). “Parental determinants of neonatal body composition.” J Clin Endocrinol.Metab 92: 523-526.

11) Kanis, J. A., Oden, A., Johnell, O., Johansson, H., De Laet, C., Brown, J., et al. (2007). “The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.” Osteoporos.Int. 18(8): 1033-1046.

12) Lips, M. A., Syddall, H. E., Gaunt, T. R., Rodriguez, S., Day, I. N., Cooper, C., et al. (2007). “Interaction between birthweight and polymorphism in the calcium-sensing receptor gene in determination of adult bone mass: the hertfordshire cohort study.” J Rheumatol. 34: 769-775.

13) Liu, B., Balkwill, A., Banks, E., Cooper, C., Green, J. and Beral, V. (2007). “Relationship of height, weight and body mass index to the risk of hip and knee replacements in middle-aged women.” Rheumatology.(Oxford) 46: 861-867.

14) Martin, R., Harvey, N. C., Crozier, S. R., Poole, J. R., Javaid, M. K., Dennison, E. M., et al. (2007). “Placental calcium transporter (PMCA3) gene expression predicts intrauterine bone mineral accrual.” Bone 40: 1203-1208.

15) Oliver, H., Jameson, K. A., Sayer, A. A., Cooper, C. and Dennison, E. M. (2007). “Growth in early life predicts bone strength in late adulthood: The Hertfordshire Cohort Study.” Bone 41(3): 400-405.

16) Seeman, E., Compston, J., Adachi, J., Brandi, M. L., Cooper, C., wson-Hughes, B., et al. (2007). “Non-compliance: the Achilles’ heel of anti-fracture efficacy.” Osteoporos.Int. 18(6): 711-719.

17) Smith, H., Anderson, F., Raphael, H., Maslin, P., Crozier, S. and Cooper, C. (2007). “Effect of annual intramuscular vitamin D on fracture risk in elderly men and women–a population-based, randomized, double-blind, placebo-controlled trial.” Rheumatology.(Oxford) 46(12): 1852-1857.

18) van Schoor, N. M., Dennison, E., Lips, P., Uitterlinden, A. G. and Cooper, C. (2007). “Serum fasting cortisol in relation to bone, and the role of genetic variations in the glucocorticoid receptor.” Clin.Endocrinol.(Oxf) 67(6): 871-878.

19) van Staa, T. P., Geusens, P., Zhang, B., Leufkens, H. G., Boonen, A. and Cooper, C. (2007). “Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.” Rheumatology.(Oxford) 46(3): 460-466.

20) van Staa, T. P., Kanis, J. A., Geusens, P., Boonen, A., Leufkens, H. G. and Cooper, C. (2007). “The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.” Value.Health 10(5): 348-357.

21) Vilarino-Guell, C., Miles, L. J., Duncan, E. L., Ralston, S. H., Compston, J. E., Cooper, C., et al. (2007). “PTHR1 polymorphisms influence BMD variation through effects on the growing skeleton.” Calcif.Tissue Int. 81(4): 270-278.

22) Wilting, I., de Vries, F., Thio, B. M., Cooper, C., Heerdink, E. R., Leufkens, H. G., et al. (2007). “Lithium use and the risk of fractures.” Bone 40: 1252-1258.

23) Ye, S., Patodi, N., Walker-Bone, K., Reading, I., Cooper, C. and Dennison, E. (2007). “Variation in the matrix metalloproteinase-3, -7, -12 and -13 genes is associated with functional status in rheumatoid arthritis.” Int J Immunogenet. 34: 81-85.

2006

1) Arden, N. and Nevitt, M. C. (2006). “Osteoarthritis: epidemiology.” Best.Pract.Res.Clin Rheumatol. 20: 3-25.

2) Arden, N. K. (2006). “Touching a raw nerve. The management of sciatica.” Arthritis Today 133: 23-24.

3) Arden, N. K., Crozier, S., Smith, H., Anderson, F., Edwards, C., Raphael, H., et al. (2006). “Knee pain, knee osteoarthritis, and the risk of fracture.” Arthritis Rheum. 55: 610-615.

4) Arden, N. K., Earl, S., Fisher, D. J., Cooper, C., Carruthers, S. and Goater, M. (2006). “Persistence with teriparatide in patients with osteoporosis: the UK experience.” Osteoporos.Int 17: 1626-1629.

5) Boonen, S., Bischoff-Ferrari, H. A., Cooper, C., Lips, P., Ljunggren, O., Meunier, P. J., et al. (2006). “Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence.” Calcif.Tissue Int 78: 257-270.

6) Carr, A. J., Thompson, P. W. and Cooper, C. (2006). “Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey.” Osteoporos.Int 17: 1638-1644.

7) Cooper, C., Aihie Sayer, A. and Dennison, E. M. (2006). The developmental environment: clinical perspectives on the effect on the musculoskeletal system. Developmental origins of health and disease. M. A. Hanson and P. Gluckman. Cambridge, Cambridge University Press: 392-405.

8) Cooper, C., Harvey, N. C., Dennison, E. M. and van Staa, T. P. (2006). “Update on the Epidemiology of Paget’s Disease of Bone.” J Bone Miner.Res. 21 Suppl 2: 3-8.

9) Cooper, C., Westlake, S., Harvey, N., Javaid, K., Dennison, E. and Hanson, M. (2006). “Review: developmental origins of osteoporotic fracture.” Osteoporos.Int 17: 337-347.

10) Cooper, C. and Woolf, A. D. (2006). Osteoporosis: best practice and research compendium. Oxford, Elsevier.

11) de Vries, F., de Vries, C., Cooper, C., Leufkens, B. and van Staa, T. P. (2006). “Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database.” Int J Epidemiol 35: 1301-1308.

12) Dennison, E., Medley, J. and Cooper, C. (2006). “Who is at risk of osteoporosis?” Women’s Health Medicine 3: 152-154.

13) Dennison, E., Mohamed, M. A. and Cooper, C. (2006). “Epidemiology of osteoporosis.” Rheum.Dis.Clin North Am 32: 617-629.

14) Dennison, E. M., Syddall, H. E., Statham, C., Aihie Sayer, A. and Cooper, C. (2006). “Relationships between SF-36 health profile and bone mineral density: the Hertfordshire Cohort Study.” Osteoporos.Int 17: 1435-1442.

15) Edwards, C. and Arden, N. (2006). “Commentary: Statins and fracture–why the confusion?” Int J Epidemiol 35: 1312-1313.

16) Edwards, C. J. and Cooper, C. (2006). “Early environmental factors and rheumatoid arthritis.” Clin Exp.Immunol. 143: 1-5.

17) Edwards, C. J., Goswami, R., Goswami, P., Syddall, H., Dennison, E. M., Arden, N. K., et al. (2006). “Growth and infectious exposure during infancy and the risk of rheumatoid factor in adult life.” Ann.Rheum.Dis. 65: 401-404.

18) Edwards, C. J., Syddall, H., Goswami, R., Goswami, P., Dennison, E. M. and Cooper, C. (2006). “Infections in infancy and the presence of antinuclear antibodies in adult life.” Lupus 15: 213-217.

19) Harvey, N., Earl, S. and Cooper, C. (2006). Epidemiology of osteoporotic fracture. Primer on the metabolic bone diseases and disorders of mineral metabolism. M. J. Favus, American Society for Bone and Mineral Research: 244-248.

20) Harvey, N., Westlake, S., Dennison, E. and Cooper, C. (2006). The epidemiology of osteoporosis. Osteoporosis and the osteoporosis of rheumatic diseases. A companion to rheumatology. N. E. Lane and P. Sambrook, Mosby: 1-13.

21) Hashimoto, J., Ohno, I., Nakatsuka, K., Yoshimura, N., Takata, S., Zamma, M., et al. (2006). “Prevalence and clinical features of Paget’s disease of bone in Japan.” J Bone Miner.Metab 24: 186-190.

22) Jakob, F., Marin, F., Martin-Mola, E., Torgerson, D., Fardellone, P., Adami, S., et al. (2006). “Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).” QJM. 99: 531-543.

23) Javaid, M. K., Crozier, S. R., Harvey, N. C., Gale, C. R., Dennison, E. M., Boucher, B. J., et al. (2006). “Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study.” Lancet 367: 36-43.

24) Javaid, M. K., Lekamwasam, S., Clark, J., Dennison, E. M., Syddall, H. E., Loveridge, N., et al. (2006). “Infant growth influences proximal femoral geometry in adulthood.” J Bone Miner.Res. 21: 508-512.

25) Jordan, K. M., Syddall, H. E., Garnero, P., Gineyts, E., Dennison, E. M., Sayer, A. A., et al. (2006). “Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men.” Ann.Rheum.Dis. 65: 871-877.

26) Kaptoge, S., Armbrecht, G., Felsenberg, D., Lunt, M., Weber, K., Boonen, S., et al. (2006). “Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study.” Osteoporos.Int 17: 1369-1381.

27) Lundkvist, J., Johnell, O., Cooper, C. and Sykes, D. (2006). “Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.” Osteoporos.Int 17: 201-211.

28) Oreffo, R., Cooper, C., Mason, C. and Clements, M. (2006). “Mesenchymal stem cells – lineage, plasticity and skeletal therapeutic potential.” Stem Cells Reviews 1: 169-178.

29) Poor, G., Donath, J., Fornet, B. and Cooper, C. (2006). “Epidemiology of Paget’s Disease in Europe: The Prevalence Is Decreasing.” J Bone Miner.Res. 21: 1545-1549.

30) Reginster, J. Y., Adami, S., Lakatos, P., Greenwald, M., Stepan, J. J., Silverman, S. L., et al. (2006). “Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.” Ann.Rheum.Dis. 65: 654-661.

31) Reginster, J. Y., Felsenberg, D., Cooper, C., Stakkestad, J. A., Miller, P. D., Kendler, D. L., et al. (2006). “A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.” Osteoporos.Int 17: 159-166.

32) Reid, D. M., Mackay, I., Wilkinson, S., Miller, C., Schuette, D. G., Compston, J., et al. (2006). “Cross-calibration of dual-energy X-ray densitometers for a large, multi-center genetic study of osteoporosis.” Osteoporos.Int 17: 125-132.

33) Roddy, E., Zhang, W., Doherty, M., Arden, N. K., Barlow, J., Birrell, F., et al. (2006). “Evidence-based clinical guidelines: a new system to better determine true strength of recommendation.” J Eval.Clin Pract. 12: 347-352.

34) Sambrook, P. and Cooper, C. (2006). “Seminar on osteoporosis. Osteoporosis: trends in epidemiology, pathogenesis and treatment.” Lancet 367: 2010-2018.

35) Staa, T. P., Geusens, P., Bijlsma, J. W., Leufkens, H. G. and Cooper, C. (2006). “Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.” Arthritis Rheum. 54: 3104-3112.

36) van Schoor, N. M., Knol, D. L., Glas, C. A., Ostelo, R. W., Leplege, A., Cooper, C., et al. (2006). “Development of the Qualeffo-31, an osteoporosis-specific quality-of-life questionnaire.” Osteoporos.Int 17: 543-551.

37) van Staa, T. P., Geusens, P., Kanis, J. A., Leufkens, H. G., Gehlbach, S. and Cooper, C. (2006). “A simple clinical score for estimating the long-term risk of fracture in post-menopausal women.” QJM. 99: 673-682.

38) Yang, X. B., Webb, D., Blaker, J., Boccaccini, A. R., Maquet, V., Cooper, C., et al. (2006). “Evaluation of human bone marrow stromal cell growth on biodegradable polymer/bioglass composites.” Biochem.Biophys.Res.Commun. 342: 1098-1107.

39) Yoshimura, N., Kinoshita, H., Hori, N., Nishioka, T., Ryujin, M., Mantani, Y., et al. (2006). “Risk factors for knee osteoarthritis in Japanese men: a case-control study.” Mod.Rheumatol. 16: 24-29.

2005

1) Adams, J., Burridge, J., Mullee, M., Hammond, A. and Cooper, C. (2005). “Self-reported hand functional ability measured by the DASH in individuals with early rheumatoid arthritis.” Br J Hand Therapy 10: 21-24.

2) Arden, N. K., Price, C., Reading, I., Stubbing, J., Hazelgrove, J., Dunne, C., et al. (2005). “A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study.” Rheumatology.(Oxford) 44: 1399-1406.

3) Arden, N. K., Syddall, H. E., Javaid, M. K., Dennison, E. M., Swaminathan, R., Fall, C., et al. (2005). “Early life influences on serum 1,25 (OH) vitamin D.” Paediatr.Perinat.Epidemiol. 19(1): 36-42.

4) Birrell, F., Arden, N. K., Conaghan, P. G., Cooper, C., Dieppe, P. and Doherty, M. (2005). “Is it time for more rheumatologists to embrace osteoarthritis?” Rheumatology.(Oxford) 44: 829-830.

5) Cooper, C. (2005). “Epidemiology of osteoporotic fracture: looking to the future.” Rheumatology.(Oxford) 44 Suppl 4: iv36-iv40.

6) Cooper, C., Javaid, K., Westlake, S., Harvey, N. and Dennison, E. (2005). “Developmental origins of osteoporotic fracture: the role of maternal vitamin d insufficiency.” J Nutr 135: 2728S-2734S.

7) Cooper, M. S., Syddall, H. E., Fall, C. H., Wood, P. J., Stewart, P. M., Cooper, C., et al. (2005). “Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study.” Clin.Endocrinol.(Oxf) 62: 692-697.

8) de Vries, F., van Staa, T. P., Bracke, M. S., Cooper, C., Leufkens, H. G. and Lammers, J. W. (2005). “Severity of obstructive airway disease and risk of osteoporotic fracture.” Eur.Respir.J 25: 879-884.

9) Delmas, P. D., Rizzoli, R., Cooper, C. and Reginster, J. Y. (2005). “Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.” Osteoporos.Int. 16(1): 1-5.

10) Dennison, E. (2005). “Osteoporosis.” Independent Nurse 31 Jan: 21-22.

11) Dennison, E., Syddall, H., Fall, C., Brandi, M. L. and Cooper, C. (2005). “Evidence of sexual dimorphism in relationships between estrogen receptor polymorphisms and bone mass: the hertfordshire study.” J Rheumatol. 32: 2400-2404.

12) Dennison, E. M., Syddall, H. E., Sayer, A. A., Gilbody, H. J. and Cooper, C. (2005). “Birth Weight and Weight at 1 Year Are Independent Determinants of Bone Mass in the Seventh Decade: The Hertfordshire Cohort Study.” Pediatr.Res. 57: 582-586.

13) Edwards, C. J., Arden, N. K., Fisher, D., Saperia, J. C., Reading, I., van Staa, T. P., et al. (2005). “The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.” Rheumatology.(Oxford) 44: 1394-1398.

14) Grant, A. M., Avenell, A., Campbell, M. K., McDonald, A. M., MacLennan, G. S., McPherson, G. C., et al. (2005). “Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.” Lancet 365: 1621-1628.

15) Harvey, N. and Cooper, C. (2005). “Physiotherapy for neck and back pain.” BMJ 330: 53-54.

16) Harvey, N. C., Dennison, E. and Cooper, C. (2005). “The epidemiology of osteoporotic fractures.” Osteoporosis Review 13: 1-5.

17) Javaid, M. K., Crozier, S. R., Harvey, N. C., Taylor, P., Inskip, H. M., Godfrey, K. M., et al. (2005). “Maternal and seasonal predictors of change in calcaneal quantitative ultrasound during pregnancy.” J Clin.Endocrinol.Metab 90: 5182-5187.

18) Javaid, M. K., Godfrey, K. M., Taylor, P., Robinson, S. M., Crozier, S. R., Dennison, E. M., et al. (2005). “Umbilical Cord Leptin Predicts Neonatal Bone Mass.” Calcif.Tissue Int 76: 341-347.

19) Jordan, K. M., Syddall, H., Dennison, E. M., Cooper, C. and Arden, N. K. (2005). “Birthweight, vitamin D receptor gene polymorphism, and risk of lumbar spine osteoarthritis.” J Rheumatol. 32: 678-683.

20) Melton, L. J., III, Chrischilles, E. A., Cooper, C., Lane, A. W. and Riggs, B. L. (2005). “How many women have osteoporosis? JBMR Anniversary Classic. JBMR, Volume 7, Number 9, 1992.” J Bone Miner.Res. 20: 886-892.

21) Miller, P. D., McClung, M. R., Macovei, L., Stakkestad, J. A., Luckey, M., Bonvoisin, B., et al. (2005). “Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1-Year Results From the MOBILE Study.” J Bone Miner.Res. 20: 1315-1322.

22) Patel, M. B., Arden, N. K., Masterson, L. M., Phillips, D. I., Swaminathan, R., Syddall, H. E., et al. (2005). “Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD).” Bone 37: 833-841.

23) Ralston, S. H., Galwey, N., Mackay, I., Albagha, O. M., Cardon, L., Compston, J. E., et al. (2005). “Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study.” Hum.Mol.Genet. 14: 943-951.

24) Reynolds, R. M., Dennison, E. M., Walker, B. R., Syddall, H. E., Wood, P. J., Andrew, R., et al. (2005). “Cortisol Secretion and Rate of Bone Loss in a Population-Based Cohort of Elderly Men and Women.” Calcif.Tissue Int 77: 134-138.

25) Roddy, E., Zhang, W., Doherty, M., Arden, N. K., Barlow, J., Birrell, F., et al. (2005). “Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee–the MOVE consensus.” Rheumatology (Oxford) 44: 67-73.

26) Tobias, J. H., Steer, C. D., Emmett, P. M., Tonkin, R. J., Cooper, C. and Ness, A. R. (2005). “Bone mass in childhood is related to maternal diet in pregnancy.” Osteoporos.Int 16: 1731-1741.

27) Trebble, T. M., Stroud, M. A., Wootton, S. A., Calder, P. C., Fine, D. R., Mullee, M. A., et al. (2005). “High-dose fish oil and antioxidants in Crohn’s disease and the response of bone turnover: a randomised controlled trial.” Br.J Nutr. 94: 253-261.

28) van Staa, T. P., Geusens, P., Pols, H. A., De Laet, C., Leufkens, H. G. and Cooper, C. (2005). “A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids.” QJM. 98(3): 191-198.

29) van Staa, T. P., Leufkens, H. G., Abenhaim, L., Zhang, B. and Cooper, C. (2005). “Use of oral corticosteroids and risk of fractures.” J Bone Miner.Res. 20: 1487-1494.